Form990


Department of the TreasuryInternal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private foundations)
MediumBullet Do not enter social security numbers on this form as it may be made public.
MediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2021
Open to Public Inspection
A For the 2021 calendar year, or tax year beginning 04-01-2021 , and ending 03-31-2022
BCheck if applicable:
CName of organization
The Susan G Komen Breast Cancer Foundation Inc
 
 
Doing business as
SUSAN G KOMEN
 
Number and street (or P.O. box if mail is not delivered to street address)
13770 NOEL ROAD SUITE 801889
 
Room/suite
City or town, state or province, country, and ZIP or foreign postal code
DALLAS, TX75380
D Employer identification number

75-1835298
E Telephone number

G Gross receipts $ 165,642,733
F Name and address of principal officer:
PAULA SUE SCHNEIDER
13770 NOEL ROAD SUITE 801889
DALLAS,TX75380
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
WWW.KOMEN.ORG
H(a)
Is this a group return for
subordinates?
H(b)
Are all subordinates
included?
If "No," attach a list. See instructions.
H(c)
Group exemption number MediumBullet  
K Form of organization:  
L Year of formation: 1982
M State of legal domicile: TX
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: OUR MISSION IS TO SAVE LIVES BY MEETING THE MOST CRITICAL NEEDS IN OUR COMMUNITIES AND INVESTING IN BREAK-THROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a) ........ 3 18
4 Number of independent voting members of the governing body (Part VI, line 1b) ..... 4 18
5 Total number of individuals employed in calendar year 2021 (Part V, line 2a) ...... 5 556
6 Total number of volunteers (estimate if necessary) ............. 6 1,456
7a Total unrelated business revenue from Part VIII, column (C), line 12 ........ 7a 10,933
b Net unrelated business taxable income from Form 990-T, Part I, line 11 ......... 7b 0
Revenues Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 50,983,746 99,456,148
9 Program service revenue (Part VIII, line 2g) ......... 3,259,501 2,500
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 7,389,057 7,437,450
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 26,113,354 4,365,358
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12) 87,745,658 111,261,456
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 15,229,334 25,691,669
14 Benefits paid to or for members (Part IX, column (A), line 4)..... 0 0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 27,327,944 36,149,496
16a Professional fundraising fees (Part IX, column (A), line 11e) ..... 1,158,758 1,181,706
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet22,781,842    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e).... 31,051,187 37,609,513
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 74,767,223 100,632,384
19 Revenue less expenses. Subtract line 18 from line 12....... 12,978,435 10,629,072
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............. 193,189,248 207,354,061
21 Total liabilities (Part X, line 26)............. 55,926,370 59,717,916
22 Net assets or fund balances. Subtract line 21 from line 20..... 137,262,878 147,636,145
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title
Paid Preparer Use Only
Print/Type preparer's name
Preparer's signature
Date
PTIN
Firm's name MediumBullet

Firm's EIN MediumBullet
Firm's address MediumBullet



Phone no.
May the IRS discuss this return with the preparer shown above? (see instructions) ..........
For Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y Form 990 (2021)
Form 990 (2021)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response or note to any line in this Part III..............
1
Briefly describe the organization’s mission: Komen's mission is to save lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer.
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? .....................
If "Yes," describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program
services? ...........................
If "Yes," describe these changes on Schedule O.
4
Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 40,955,788 including grants of $ 4,503,337 ) (Revenue $ -5,448 )
PATIENT CARE AND ADVOCACY: PROVISION OF BREAST CANCER SCREENING, DIAGNOSIS, AND TREATMENT PROGRAMS THROUGH GRANTS TO OTHER NON-PROFIT ORGANIZATIONS, THIRD-PARTY CONTRACTS AND DIRECTLY BY KOMEN, WITH A SPECIAL EMPHASIS ON PATIENT NAVIGATION, ESPECIALLY IN COMMUNITIES WHERE DISPARITIES IN OUTCOMES ARE SIGNIFICANT AND/OR ACCESS IS LIMITED. SEE SCHEDULE O FOR ADDITIONAL DETAILS.
4b (Code:   ) (Expenses $ 24,901,656 including grants of $ 21,181,617 ) (Revenue $ 2,500 )
GRANTS TO RESEARCH INSTITUTIONS AND OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER RESEARCH PROJECTS INCLUDING THOSE FOCUSED ON THE BIOLOGY OF BREAST CANCER; NEW STRATEGIES TO TREAT, DETECT, AND PREDICT RISK OF BREAST CANCER, AND UNDERSTANDING AND ADDRESSING DISPARITIES IN OUTCOMES. SEE SCHEDULE O FOR ADDITIONAL DETAILS.
4c (Code:   ) (Expenses $   including grants of $   ) (Revenue $   )
4d Other program services (Describe in Schedule O.)
(Expenses $   including grants of $   ) (Revenue $   )
4e Total program service expensesMediumBullet65,857,444
Form 990 (2021)
Form 990 (2021)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule AClick to see attachment.....................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors? See instructions. Click to see attachment...
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part I.............
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part IIClick to see attachment.........
4
Yes
 
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Rev. Proc. 98-19? If "Yes," complete Schedule C, Part III..
5
 
 
6
Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes," complete Schedule D, Part I.........................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part II....
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes,"
complete Schedule D, Part III..............
8
 
No
9
Did the organization report an amount in Part X, line 21 for escrow or custodial account liability; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IV..............
9
 
No
10
Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi endowments? If "Yes," complete Schedule D, Part VClick to see attachment......
10
Yes
 
11
If the organization’s answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, VIII, IX, or X, as applicable.
a
Did the organization report an amount for land, buildings, and equipment in Part X, line 10? If "Yes," complete
Schedule D, Part VI. Click to see attachment...................
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIClick to see attachment.......
11b
Yes
 
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIII.......
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part IX............
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If "Yes," complete Schedule D, Part X
11e
 
No
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If "Yes," complete Schedule D, Part XClick to see attachment
11f
Yes
 
12a
Did the organization obtain separate, independent audited financial statements for the tax year? If "Yes," complete
Schedule D, Parts XI and XII......................
12a
 
No
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 12a, then completing Schedule D, Parts XI and XII is optional Click to see attachment
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If "Yes," complete Schedule E
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States? .....
14a
 
No
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts I and IV.........Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? If “Yes,” complete Schedule F, Parts II and IV.....Click to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If “Yes,” complete Schedule F, Parts III and IV...
16
 
No
17
Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If "Yes," complete Schedule G, Part I. See instructions. ....Click to see attachment
17
Yes
 
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If "Yes," complete Schedule G, Part II............ Click to see attachment
18
Yes
 
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If "Yes," complete Schedule G, Part III...................
19
 
No
20a
Did the organization operate one or more hospital facilities? If "Yes," complete Schedule H....
20a
 
No
b
If "Yes" to line 20a, did the organization attach a copy of its audited financial statements to this return?
20b
 
 
21
Did the organization report more than $5,000 of grants or other assistance to any domestic organization or domestic government on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.....Click to see attachment
21
Yes
 
Form 990 (2021)
Form 990 (2021)
Page 4
Part IV
Checklist of Required Schedules (continued)
Yes
No
22
Did the organization report more than $5,000 of grants or other assistance to or for domestic individuals on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III........Click to see attachment
22
Yes
 
23
Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5, about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If "Yes," complete Schedule J....................... Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer lines 24b through 24d and complete Schedule K. If “No,” go to line 25a...............
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds? ...............
24c
 
 
d
Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3), 501(c)(4), and 501(c)(29) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If "Yes," complete Schedule L, Part I ....
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If "Yes," complete Schedule L, Part I.......................
25b
 
No
26
Did the organization report any amount on Part X, line 5 or 22 for receivables from or payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons? If "Yes," complete Schedule L, Part II...........
26
 
No
27
Did the organization provide a grant or other assistance to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or employee thereof, a grant selection committee member, or to a 35% controlled entity (including an employee thereof) or family member of any of these persons?
If "Yes," complete
Schedule L, Part III.........................
27
 
No
28
Was the organization a party to a business transaction with one of the following parties (see the Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, key employee, creator or founder, or substantial contributor? If "Yes," complete Schedule L, Part IV......................
28a
 
No
b
A family member of any individual described in line 28a? If "Yes," complete Schedule L, Part IV.....
28b
 
No
c
A 35% controlled entity of one or more individuals and/or organizations described in line 28a or 28b? If "Yes," complete Schedule L, Part IV.....................
28c
 
No
29
Did the organization receive more than $25,000 in non-cash contributions? If "Yes," complete Schedule M..Click to see attachment
29
Yes
 
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If "Yes," complete Schedule M .................
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N, Part I
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes," complete Schedule N, Part II........................
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If "Yes," complete Schedule R, Part I............
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If "Yes," complete Schedule R, Part II, III, or IV, and Part V, line 1.........................
34
 
No
35a
Did the organization have a controlled entity within the meaning of section 512(b)(13)?
35a
 
No
b
If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule R, Part V, line 2 ...
35b
 
 
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If "Yes," complete Schedule R, Part V, line 2.............
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes," complete Schedule R, Part VI
37
 
No
38
Did the organization complete Schedule O and provide explanations on Schedule O for Part VI, lines 11b and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response or note to any line in this Part V...........
Yes
No
1a
Enter the number reported in box 3 of Form 1096. Enter -0- if not applicable ..
1a
133
b
Enter the number of Forms W-2G included on line 1a. Enter -0- if not applicable .
1b
0
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
Yes
 
Form 990 (2021)
Form 990 (2021)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance (continued)
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and
Tax Statements, filed for the calendar year ending with or within the year covered by this return ..................
2a
556
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?
Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file. See instructions.
2b
Yes
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?...
3a
Yes
 
b
If “Yes,” has it filed a Form 990-T for this year? If “No” to line 3b, provide an explanation in Schedule O...
3b
Yes
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account, securities account, or other financial account)? ..
4a
 
No
b
If "Yes," enter the name of the foreign country: MediumBullet
See instructions for filing requirements for FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR).
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year? ..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If "Yes," to line 5a or 5b, did the organization file Form 8886-T? ............
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions? ...
6a
 
No
b
If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible? ......................
6b
 
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor? ....................
7a
Yes
 
b
If "Yes," did the organization notify the donor of the value of the goods or services provided? .....
7b
Yes
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282? .........................
7c
Yes
 
d
If "Yes," indicate the number of Forms 8282 filed during the year ....
7d
1
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required? ......................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C? ..........................
7h
 
 
8
Sponsoring organizations maintaining donor advised funds. Did a donor advised fund maintained by the sponsoring organization have excess business holdings at any time during the year? ........
8
 
 
9
Sponsoring organizations maintaining donor advised funds.
a
Did the sponsoring organization make any taxable distributions under section 4966?........
9a
 
 
b
Did the sponsoring organization make a distribution to a donor, donor advisor, or related person?...
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources. (Do not net amounts due or paid to other sources against amounts due or received from them.) ..........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If "Yes," enter the amount of tax-exempt interest received or accrued during the year.
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state? .........
Note. See the instructions for additional information the organization must report on Schedule O.
13a
 
 
b
Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans ....
13b
 
c
Enter the amount of reserves on hand ............
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
No
b
If "Yes," has it filed a Form 720 to report these payments? If "No," provide an explanation in Schedule O..
14b
 
 
15
Is the organization subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or excess parachute payment(s) during the year? ....................
If "Yes," see the instructions and file Form 4720, Schedule N.
15
 
No
16
Is the organization an educational institution subject to the section 4968 excise tax on net investment income? ..
If "Yes," complete Form 4720, Schedule O.
16
 
No
17
Section 501(c)(21) organizations. Did the trust, any disqualified person, or mine operator engage in any activities that would result in the imposition of an excise tax under section 4951, 4952, or 4953? ..
If "Yes," complete Form 6069.
17
 
 
Form 990 (2021)
Form 990 (2021)
Page 6
Part VI
Governance, Management, and Disclosure. For each "Yes" response to lines 2 through 7b below, and for a "No" response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response or note to any line in this Part VI..............
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year
1a
18
If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.
b
Enter the number of voting members included in line 1a, above, who are independent
1b
18
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed? .
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Did the organization have members or stockholders? ................
6
 
No
7a
Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? ....................
7a
 
No
b
Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ...................
7b
 
No
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .......................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If "Yes," provide the names and addresses in Schedule O.......
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal Revenue Code.)
Yes
No
10a
Did the organization have local chapters, branches, or affiliates? ............
10a
Yes
 
b
If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes?
10b
Yes
 
11a
Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? ............................
11a
Yes
 
b
Describe on Schedule O the process, if any, used by the organization to review this Form 990. .....
12a
Did the organization have a written conflict of interest policy? If "No," go to line 13.......
12a
Yes
 
b
Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ..........................
12b
Yes
 
c
Did the organization regularly and consistently monitor and enforce compliance with the policy? If "Yes," describe on Schedule O how this was done...................
12c
Yes
 
13
Did the organization have a written whistleblower policy? ...............
13
Yes
 
14
Did the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
Yes
 
b
Other officers or key employees of the organization ................
15b
Yes
 
If "Yes" to line 15a or 15b, describe the process on Schedule O. See instructions.
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the states with which a copy of this Form 990 is required to be filedMediumBullet
CA , CO , CT , DC , FL , GA , AL , HI , IL , IN , KS , KY , ME , AK , MD , MA , MI , MN , MS , MO , NH , NJ , NM , NY , NC , ND , OH , OK , OR , PA , AZ , RI , SC , TN , UT , VA , AR , WA , WV , WI
18
Section 6104 requires an organization to make its Form 1023 (1024 or 1024-A, if applicable), 990, and 990-T (section 501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.
20
State the name, address, and telephone number of the person who possesses the organization's books and records:
MediumBulletRIA WILLIAMS13770 NOEL ROAD SUITE 801889   DALLAS,TX75380 (972) 855-1600
Form 990 (2021)
Form 990 (2021)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response or note to any line in this Part VII..............
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See the instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (box 5 of Form W-2, Form 1099-MISC, and/or box 1 of Form 1099-NEC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

See the instructions for the order in which to list the persons above.
Check this box if neither the organization nor any related organization compensated any current officer, director, or trustee.
(A)
Name and title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W-2/1099-MISC/1099-NEC) 		(E)
Reportable compensation from related organizations (W-2/1099-MISC/1099-NEC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(1) Ed Dandridge
 
Chair of the Board (BEG Jun 2021 )
 1.0
.................
0 		X   X       0 0 0
(2) Jerri Johnson
 
BOD Member (Vice Chair BEG Mar 2021
 1.0
.................
0 		X   X       0 0 0
(3) Andi Owen
 
BOD Member (BEG Mar 2021)
 1.0
.................
0 		X           0 0 0
(4) BJ Schaknowski
 
BOD Member (BEG Mar 2022)
 1.0
.................
0 		X           0 0 0
(5) Christina Minnis
 
BOD Member
 1.0
.................
0 		X           0 0 0
(6) Eugene Kim
 
BOD Member (END Mar 2022)
 1.0
.................
0 		X           0 0 0
(7) Gail Heimann
 
BOD Member (BEG Mar 2021)
 1.0
.................
0 		X           0 0 0
(8) John O'Neill
 
BOD Member
 1.0
.................
0 		X           0 0 0
(9) Julia Harris
 
BOD Member (BEG Mar 2021)
 1.0
.................
0 		X           0 0 0
(10) Julie Gruber
 
BOD Member (BEG Mar 2022)
 1.0
.................
0 		X           0 0 0
(11) Kristen Racich
 
BOD Member (BEG Mar 2022)
 1.0
.................
0 		X           0 0 0
(12) Kwanza Jones
 
BOD Member (END Mar 2022)
 1.0
.................
0 		X           0 0 0
(13) Luke Sauter
 
BOD Member (BEG Mar 2021)
 1.0
.................
0 		X           0 0 0
(14) Lydia The
 
BOD Member (BEG Mar 2022)
 1.0
.................
0 		X           0 0 0
(15) Michelle Bottomley
 
BOD Member (BEG Mar 2021)
 1.0
.................
0 		X           0 0 0
(16) Peter D Brundage
 
BOD Member (frmr Chair, Chair end Jun 2021)
 1.0
.................
0 		X           0 0 0
(17) Renee Baker
 
BOD Member (BEG Mar 2021)
 1.0
.................
0 		X           0 0 0
Form 990 (2021)
Form 990 (2021)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W-2/1099-MISC/1099-NEC) 		(E)
Reportable compensation from related organizations (W-2/1099-MISC/1099-NEC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(18) Robyn Shepherd
 
BOD Member (BEG Mar 2022)
 1.0
.......................0 		X           0 0 0
(19) Sean Slovenski
 
BOD Member (BEG Mar 2021)
 1.0
.......................0 		X           0 0 0
(20) Susannah Gray
 
BOD Member (END Mar 2022)
 1.0
.......................0 		X           0 0 0
(21) Traci Blunt
 
BOD Member (BEG Mar 2021)
 1.0
.......................0 		X           0 0 0
(22) Dana Brown
 
Chief Operating Officer
 55.0
.......................0 		    X       465,537 0 15,637
(23) Eunice Nakamura
 
General Counsel & Corporate Secretary
 55.0
.......................0 		    X       269,473 0 14,336
(24) Paula Schneider
 
President and CEO
 55.0
.......................0 		    X       682,520 0 31,412
(25) Ria Williams
 
Chief Financial Officer
 55.0
.......................0 		    X       290,183 0 21,782
(26) Catherine Olivieri
 
SVP, Human Resources
 55.0
.......................0 		      X     289,457 0 22,580
(27) Lori Maris
 
SVP, Ops Services & Support
 55.0
.......................0 		      X     243,277 0 12,596
(28) Victoria Wolodzko
 
SVP, Mission
 55.0
.......................0 		      X     340,267 0 9,729
(29) Kari Bodell
 
VP, Dev Progs Strat
 55.0
.......................0 		        X   229,605 0 7,955
(30) Kimberly Sabelko
 
VP, Sci Strat & Programs
 55.0
.......................0 		        X   202,212 0 15,723
(31) Michelle Strong
 
VP, Marketing Strat
 55.0
.......................0 		        X   225,607 0 13,095
(32) Sarah Rosales
 
VP, Corp Partnerships
 55.0
.......................0 		        X   233,478 0 16,798
(33) Srinivasu Avadhanula
 
VP, BI Platfm & Eng
 55.0
.......................0 		        X   241,720 0 7,910
(34) Kimberly Johnson
 
Former Sr. Director AAHEI
  
.......................0.0 		          X 182,424 0 1,769
1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)...........MediumBullet 3,895,760 0 191,322
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organization MediumBullet92
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If "Yes," complete Schedule J for such individual ..............
3
 
No
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If "Yes," complete Schedule J for such
individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If "Yes," complete Schedule J for such person ........
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
Event 360

205 N Michigan Ave
Chicago,IL60601 		Event Management 2,349,796
RKD Group LLC

3400 Waterview Parkway
Richardson,TX75080 		Consulting 1,086,596
CSM Sport & Entertainment Inc

8770 Guion Road
Indianapolis,IN46268 		Consulting 458,250
Ernst & Young

3712 Solutions Center
Chicago,IL60677 		Acctg & Tax Services 329,983
MSB Financial Solutions LLC

79 Cherrywood Dr
Nashua,NH03062 		Consulting 323,309
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization MediumBullet20
Form 990 (2021)
Form 990 (2021)
Page 9
Part VIII
Statement of Revenue
Check if Schedule O contains a response or note to any line in this Part VIII.............
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512 - 514
Contributions, Gifts, Grants, and OtherAmt Similar Amounts 1a Federated campaigns..1a 262,529
b Membership dues..1b 0
c Fundraising events..1c 25,041,236
d Related organizations1d 0
e Government grants (contributions)1e 4,527,545
f All other contributions, gifts, grants, and similar amounts not included above1f 69,624,838
g Noncash contributions included in lines 1a - 1f:$ 1g 182,327
h Total. Add lines 1a-1f.......MediumBullet 99,456,148
Program Service RevenueAmt Business Code
2a Affiliate Treatment Assistance Fund 900099 2,500 2,500 0 0
b     0 0 0 0
c     0 0 0 0
d     0 0 0 0
e     0 0 0 0
f All other program service revenue. 0 0 0 0
g Total. Add lines 2a–2f .....MediumBullet 2,500
OtherAmtRevenueAmt 3 Investment income (including dividends, interest, and othersimilar amounts) ......MediumBullet 1,152,853 0 0 1,152,853
4 Income from investment of tax-exempt bond proceedsMediumBullet 0 0 0 0
5 Royalties...........MediumBullet 3,507 0 0 3,507
(ii) Personal (i) Real
6a Gross rents 0 0 6a
b Less: rental expenses 0 0 6b
c Rental income or (loss) 0 0 6c
d Net rental income or (loss).......MediumBullet 0 0 0 0
(ii) Other (i) Securities
7a Gross amount from sales of assets other than inventory 0 56,458,504 7a
b Less: cost or other basis and sales expenses 0 50,173,907 7b
c Gain or (loss) 0 6,284,597 7c
d Net gain or (loss).........MediumBullet 6,284,597 0 0 6,284,597
8a Gross income from fundraising events (not including $ 25,041,236of contributions reported on line 1c). See Part IV, line 18 ....
8a 977,618
b Less: direct expenses ... 8b 4,150,957
c Net income or (loss) from fundraising events..MediumBullet -3,173,339 0 -3,173,339
9a Gross income from gaming activities.
See Part IV, line 19 ...
9a 4,642
b Less: direct expenses ... 9b 31,204
c Net income or (loss) from gaming activities..MediumBullet -26,562 0 0 -26,562
10a Gross sales of inventory, less
returns and allowances ..
10a 14,061
b Less: cost of goods sold .. 10b 25,209
c Net income or (loss) from sales of inventory..MediumBullet -11,148 -11,148 0 0
Business Code Miscellaneous Revenue
11a SHARED SERVICES 900099 5,700 5,700 0 0
b OTHER INCOME 900099 3,574 0 10,933 -7,359
c MERGER RELATED INCOME 900099 7,563,626 0 0 7,563,626
d All other revenue .... 0 0 0 0
e Total. Add lines 11a–11d ...... MediumBullet 7,572,900
12 Total revenue. See instructions.....MediumBullet 111,261,456 -2,948 10,933 11,797,323
Form 990 (2021)
Form 990 (2021)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A).Check if Schedule O contains a response or note to any line in this Part IX..............
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising
expenses
1 Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21 .... 21,294,309 21,294,309
2 Grants and other assistance to domestic individuals. See Part IV, line 22 ........... 3,829,950 3,829,950
3 Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, lines 15 and 16. ............. 567,410 567,410
4 Benefits paid to or for members ....... 0 0
5 Compensation of current officers, directors, trustees, and key employees ........... 2,708,786 1,405,372 658,068 645,346
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ......... 0 0 0 0
7 Other salaries and wages........ 28,161,837 14,624,022 6,764,699 6,773,116
8 Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) .... 783,595 402,287 206,904 174,404
9 Other employee benefits ....... 2,420,853 1,196,985 686,865 537,003
10 Payroll taxes ........... 2,074,425 1,082,439 487,763 504,223
11 Fees for services (non-employees):        
a Management ...... 0 0 0 0
b Legal ......... 242,415 97,066 48,283 97,066
c Accounting ........... 508,141 57,633 392,894 57,614
d Lobbying ........... 204,997 204,997 0 0
e Professional fundraising services. See Part IV, line 17 1,181,706 1,181,706
f Investment management fees ...... 179,154 0 179,154 0
g Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) 0 0 0 0
12 Advertising and promotion .... 5,010,574 2,770,603 336,748 1,903,223
13 Office expenses ....... 16,533,412 8,238,874 130,075 8,164,463
14 Information technology ...... 1,863,957 745,583 559,187 559,187
15 Royalties .. 0 0 0 0
16 Occupancy ........... 198,411 125,740 38,890 33,781
17 Travel ............ 276,760 144,731 44,116 87,913
18 Payments of travel or entertainment expenses for any federal, state, or local public officials . 0 0 0 0
19 Conferences, conventions, and meetings .... 211,178 77,693 50,538 82,947
20 Interest ........... 0 0 0 0
21 Payments to affiliates ....... 0 0 0 0
22 Depreciation, depletion, and amortization .. 900,298 665,856 126,593 107,849
23 Insurance ... 543,188 543,188 0 0
24 Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a CONSULT & PROF. FEES 6,641,802 5,326,482 556,519 758,801
b EQUIP RENTAL & MAINT 1,744,826 1,102,803 346,119 295,904
c EVENT PRODUCTION 108,740 40,854 23,002 44,884
d MERCHANT SERVICES & BANK FEES 1,367,858 777,580 94,358 495,920
e All other expenses 1,073,802 534,981 262,329 276,492
25 Total functional expenses. Add lines 1 through 24e 100,632,384 65,857,438 11,993,104 22,781,842
26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here MediumBullet if following SOP 98-2 (ASC 958-720). 42,779,147 21,416,390 1,814,928 19,547,829
Form 990 (2021)
Form 990 (2021)
Page 11
Part X
Balance Sheet
Check if Schedule O contains a response or note to any line in this Part IX..............
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash–non-interest-bearing ........ 0 1 0
2 Savings and temporary cash investments ......... 27,119,307 2 23,067,395
3 Pledges and grants receivable, net ...... 20,276,918 3 15,045,253
4 Accounts receivable, net ............. 0 4 0
5 Loans and other receivables from any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .......
0 5 0
6 Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), and persons described in section 4958(c)(3)(B) ...
0 6 0
7 Notes and loans receivable, net ........... 0 7 0
8 Inventories for sale or use ............ 6,957 8 9,577
9 Prepaid expenses and deferred charges ...... 2,239,524 9 2,120,424
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 12,062,424
b Less: accumulated depreciation 10b 8,416,953 2,249,769 10c 3,645,471
11 Investments—publicly traded securities . 102,135,416 11 119,988,473
12 Investments—other securities. See Part IV, line 11 ..... 39,150,000 12 43,470,000
13 Investments—program-related. See Part IV, line 11 .. 0 13  
14 Intangible assets ............... 0 14 0
15 Other assets. See Part IV, line 11 ........... 11,357 15 7,468
16 Total assets. Add lines 1 through 15 (must equal line 33)... 193,189,248 16 207,354,061
Liabilities 17 Accounts payable and accrued expenses ..... 9,143,376 17 9,791,057
18 Grants payable ... 41,640,671 18 49,697,151
19 Deferred revenue ......... 614,778 19 229,708
20 Tax-exempt bond liabilities ......... 0 20 0
21 Escrow or custodial account liability. Complete Part IV of Schedule D 0 21 0
22 Loans and other payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .........
0 22 0
23 Secured mortgages and notes payable to unrelated third parties .. 4,527,545 23 0
24 Unsecured notes and loans payable to unrelated third parties .. 0 24 0
25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17 - 24). Complete Part X of Schedule D 0 25 0
26 Total liabilities. Add lines 17 through 25.. 55,926,370 26 59,717,916
Net Assets or Fund Balance Organizations that follow FASB ASC 958, check here MediumBullet and complete lines 27, 28, 32, and 33.
27 Net assets without donor restrictions .......... 90,698,864 27 98,403,421
28 Net assets with donor restrictions ........... 46,564,014 28 49,232,724
Organizations that do not follow FASB ASC 958, check here MediumBullet and complete lines 29 through 33.
29 Capital stock or trust principal, or current funds ..... 0 29 0
30 Paid-in or capital surplus, or land, building or equipment fund ... 0 30 0
31 Retained earnings, endowment, accumulated income, or other funds 0 31 0
32 Total net assets or fund balances ........... 137,262,878 32 147,636,145
33 Total liabilities and net assets/fund balances ........ 193,189,248 33 207,354,061
Form 990 (2021)
Form 990 (2021)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response or note to any line in this Part XI..............
1
Total revenue (must equal Part VIII, column (A), line 12) ............
1
111,261,456
2
Total expenses (must equal Part IX, column (A), line 25) ............
2
100,632,384
3
Revenue less expenses. Subtract line 2 from line 1 ..............
3
10,629,072
4
Net assets or fund balances at beginning of year (must equal Part X, line 32, column (A)) ..
4
137,262,878
5
Net unrealized gains (losses) on investments ...............
5
-693,580
6
Donated services and use of facilities .................
6
-179,874
7
Investment expenses .....................
7
0
8
Prior period adjustments .....................
8
 
9
Other changes in net assets or fund balances (explain in Schedule O) ........
9
617,649
10
Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 32, column (B))
10
147,636,145
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response or note to any line in this Part XII.............
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain on
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?
2a
 
No
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both:
b
Were the organization’s financial statements audited by an independent accountant?
2b
Yes
 
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both:
c
If "Yes," to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
2c
Yes
 
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O.
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133?
3a
 
No
b
If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits.
3b
 
 
Form 990 (2021)
Form 990 (2021)
Additional Data


Software ID: 21014044
Software Version: 2021v4.2
Form 990, Special Condition Description:
Special Condition Description
SCHEDULE A
(Form 990)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support
Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ.
right arrow Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2021
Open to Public
Inspection
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number

75-1835298
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions.
The organization is not a private foundation because it is: (For lines 1 through 12, check only one box.)
1
2
3
4
5
6
7
8
9
10
11
12
a
b
c
d
e
f
Enter the number of supported organizations ...............................  
g
Provide the following information about the supported organization(s).
(i) Name of supported organization (ii) EIN (iii) Type of organization (described on lines 1- 10 above (see instructions)) (iv) Is the organization listed in your governing document? (v) Amount of monetary support (see instructions) (vi) Amount of other support (see instructions)
Yes No
Total
 
   
For Paperwork Reduction Act Notice, see the Instructions for
Form 990 or 990-EZ.
Cat. No. 11285F
Schedule A (Form 990) 2021

Schedule A (Form 990) 2021
Page 2
Part II
Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization failed to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2017 (b) 2018 (c) 2019 (d) 2020 (e) 2021 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. 51,441,732 63,291,987 59,972,314 50,983,746 99,456,148 325,145,927
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....           0
3 The value of services or facilities furnished by a governmental unit to the organization without charge..           0
4 Total. Add lines 1 through 3 51,441,732 63,291,987 59,972,314 50,983,746 99,456,148 325,145,927
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. 20,149,718
6 Public support. Subtract line 5 from line 4. 304,996,209
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2017 (b) 2018 (c) 2019 (d) 2020 (e) 2021 (f) Total
7 Amounts from line 4.. 51,441,732 63,291,987 59,972,314 50,983,746 99,456,148 325,145,927
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... 5,667,273 5,221,701 4,928,838 1,217,543 1,156,360 18,191,715
9 Net income from unrelated business activities, whether or not the business is regularly carried on..           0
10 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. 124,523 34,200 86,442 15,070 3,574 263,809
11 Total support. Add lines 7 through 10 343,601,451
12
12
81,700,047
13
First 5 years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here ........................................right arrow
Section C. Computation of Public Support Percentage
14
14
88.76 %
15
15
81.99 %
16a
b
17a
b
18
Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow
Schedule A (Form 990) 2021

Schedule A (Form 990) 2021
Page 3
Part III
Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 10 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2017 (b) 2018 (c) 2019 (d) 2020 (e) 2021 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose            
3 Gross receipts from activities that are not an unrelated trade or business under section 513 .....            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge            
6 Total. Add lines 1 through 5            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public support. (Subtract line 7c from line 6.)  
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2017 (b) 2018 (c) 2019 (d) 2020 (e) 2021 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..            
13 Total support. (Add lines 9, 10c, 11, and 12.)..            
14
Section C. Computation of Public Support Percentage
15
15
 
16
16
 
Section D. Computation of Investment Income Percentage
17
17
 
18
18
 
19a
b
20
Schedule A (Form 990) 2021

Schedule A (Form 990) 2021
Page 4
Part IV
Supporting Organizations
(Complete only if you checked a box on line 12 of Part I. If you checked box 12a, of Part I, complete Sections A and B. If you checked box 12b, of Part I, complete Sections A and C. If you checked box 12c, of Part I, complete Sections A, D, and E. If you checked box12d, of Part I, complete Sections A and D, and complete Part V.)
Section A. All Supporting Organizations
Yes
No
1
Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.
1
 
 
2
Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).
2
 
 
3a
Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer lines 3b and 3c below.
3a
 
 
b
Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.
3b
 
 
c
Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.
3c
 
 
4a
Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked box 12a or 12b in Part I, answer lines 4b and 4c below.
4a
 
 
b
Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations.
4b
 
 
c
Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.
4c
 
 
5a
Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer lines 5b and 5c below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed; (ii) the reasons for each such action; (iii) the authority under the organization's organizing document authorizing such action; and (iv) how the action was accomplished (such as by amendment to the organizing document).
5a
 
 
b
Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?
5b
 
 
c
Substitutions only. Was the substitution the result of an event beyond the organization's control?
5c
 
 
6
Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (i) its supported organizations, (ii) individuals that are part of the charitable class benefited by one or more of its supported organizations, or (iii) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.
6
 
 
7
Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in section 4958(c)(3)(C)), a family member of a substantial contributor, or a 35% controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990) .
7
 
 
8
Did the organization make a loan to a disqualified person (as defined in section 4958) not described on line 7? If “Yes,” complete Part I of Schedule L (Form 990).
8
 
 
9a
Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons, as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.
9a
 
 
b
Did one or more disqualified persons (as defined on line 9a) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.
9b
 
 
c
Did a disqualified person (as defined on line 9a) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.
9c
 
 
10a
Was the organization subject to the excess business holdings rules of section 4943 because of section 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer line 10b below.
10a
 
 
b
Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).
10b
 
 
Schedule A (Form 990) 2021

Schedule A (Form 990) 2021
Page 5
Part IV
Supporting Organizations (continued)
Yes
No
11
Has the organization accepted a gift or contribution from any of the following persons?
a
A person who directly or indirectly controls, either alone or together with persons described on lines 11b and 11c below, the governing body of a supported organization?
11a
 
 
b
A family member of a person described on 11a above?
11b
 
 
c
A 35% controlled entity of a person described on line 11a or 11b above? If “Yes” to 11a, 11b, or 11c, provide detail in Part VI.
11c
 
 
Section B. Type I Supporting Organizations
Yes
No
1
Did the officers, directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.
1
 
 
2
Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.
2
 
 
Section C. Type II Supporting Organizations
Yes
No
1
Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).
1
 
 
Section D. All Type III Supporting Organizations
Yes
No
1
Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (i) a written notice describing the type and amount of support provided during the prior tax year, (ii) a copy of the Form 990 that was most recently filed as of the date of notification, and (iii) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?
1
 
 
2
Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).
2
 
 
3
By reason of the relationship described in line 2 above, did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.
3
 
 
Section E. Type III Functionally-Integrated Supporting Organizations
1
Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):
a
b
c
2
Activities Test. Answer lines 2a and 2b below.
Yes
No
a
Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.
2a
 
 
b
Did the activities described on line 2a, above constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.
2b
 
 
3
Parent of Supported Organizations. Answer lines 3a and 3b below.
a
Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations?If "Yes" or "No", provide details in Part VI.
3a
 
 
b
Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI. the role played by the organization in this regard.
3b
 
 
Schedule A (Form 990) 2021

Schedule A (Form 990) 2021
Page 6
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations
1
Section A - Adjusted Net Income (A) Prior Year (B) Current Year
(optional)
1 Net short-term capital gain 1    
2 Recoveries of prior-year distributions 2    
3 Other gross income (see instructions) 3    
4 Add lines 1 through 3 4    
5 Depreciation and depletion 5    
6 Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) 6    
7 Other expenses (see instructions) 7    
8 Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) 8    
Section B - Minimum Asset Amount (A) Prior Year (B) Current Year
(optional)
1 Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): 1
a Average monthly value of securities 1a    
b Average monthly cash balances 1b    
c Fair market value of other non-exempt-use assets 1c    
d Total (add lines 1a, 1b, and 1c) 1d    
e Discount claimed for blockage or other factors
(explain in detail in Part VI):  
2 Acquisition indebtedness applicable to non-exempt use assets 2    
3 Subtract line 2 from line 1d 3    
4 Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). 4    
5 Net value of non-exempt-use assets (subtract line 4 from line 3) 5    
6 Multiply line 5 by 0.035 6    
7 Recoveries of prior-year distributions 7    
8 Minimum Asset Amount (add line 7 to line 6) 8    
Section C - Distributable Amount Current Year
1 Adjusted net income for prior year (from Section A, line 8, Column A) 1  
2 Enter 85% of line 1 2  
3 Minimum asset amount for prior year (from Section B, line 8, Column A) 3  
4 Enter greater of line 2 or line 3 4  
5 Income tax imposed in prior year 5  
6 Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) 6  
7
Schedule A (Form 990) 2021

Schedule A (Form 990) 2021
Page 7
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations(continued)
Section D - Distributions Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes 1  
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in
excess of income from activity 		2  
3 Administrative expenses paid to accomplish exempt purposes of supported organizations 3  
4 Amounts paid to acquire exempt-use assets 4  
5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) 5  
6 Other distributions (describe in Part VI). See instructions 6  
7Total annual distributions. Add lines 1 through 6. 7  
8 Distributions to attentive supported organizations to which the organization is responsive (provide
details in Part VI). See instructions 		8  
9 Distributable amount for 2021 from Section C, line 6 9  
10 Line 8 amount divided by Line 9 amount 10  
Section E - Distribution Allocations (see instructions) (i)
Excess Distributions 		(ii)
Underdistributions
Pre-2021 		(iii)
Distributable
Amount for 2021
1 Distributable amount for 2021 from Section C, line 6  
2 Underdistributions, if any, for years prior to 2021 (reasonable cause required-- explain in Part VI).
See instructions.		  
3 Excess distributions carryover, if any, to 2021:
a From 2016.......  
b From 2017.......  
c From 2018.......  
d From 2019.......  
e From 2020.......  
fTotal of lines 3a through e  
g Applied to underdistributions of prior years  
h Applied to 2021 distributable amount  
i Carryover from 2016 not applied (see
instructions) 		 
j Remainder. Subtract lines 3g, 3h, and 3i from line 3f.  
4Distributions for 2021 from Section D, line 7:
$  
a Applied to underdistributions of prior years  
b Applied to 2021 distributable amount  
c Remainder. Subtract lines 4a and 4b from line 4.  
5 Remaining underdistributions for years prior to
2021, if any. Subtract lines 3g and 4a from line 2.
If the amount is greater than zero, explain in Part VI.
See instructions. 		 
6 Remaining underdistributions for 2021. Subtract
lines 3h and 4b from line 1. If the amount is greater
than zero, explain in Part VI. See instructions. 		 
7 Excess distributions carryover to 2022. Add lines
3j and 4c. 		 
8 Breakdown of line 7:
a Excess from 2017.....  
b Excess from 2018.....  
c Excess from 2019.....  
d Excess from 2020.....  
e Excess from 2021.....  
Schedule A (Form 990) (2021)

Schedule A (Form 990) 2021
Page 8
Part VI
Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Return Reference Explanation
Schedule A, Part II, Line 10 Other Income DESCRIPTION - OTHER INCOME, COLUMN A - 124523.0, COLUMN B - 34200.0, COLUMN C - 86442.0, COLUMN D - 15070.0, COLUMN E - 3574.0, COLUMN F - 263809.0;
Schedule A (Form 990) 2021


Additional Data


Software ID: 21014044
Software Version: 2021v4.2
Schedule B
(Form 990)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors

Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
Arrow Bullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2021
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number

75-1835298
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ






Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note: Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule
Special Rules
......... Arrow Bullet $  
Caution: An organization that isn't covered by the General Rule and/or the Special Rules doesn't file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its Form 990-EZ
or on its Form 990PF, Part I, line 2, to certify that it doesn't meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990) (2021)
Schedule B (Form 990) (2021) Page 2
Name of organization
The Susan G Komen Breast Cancer Foundation Inc
  		Employer identification number
75-1835298
Part I
Contributors
Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
RESTRICTED
 
 
 
 
  ,    

$ RESTRICTED


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
Schedule B (Form 990) (2021)
Schedule B (Form 990) (2021)
Page 3
Name of organization
The Susan G Komen Breast Cancer Foundation Inc
  		Employer identification number

75-1835298
Part II
Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
Schedule B (Form 990) (2021)
Schedule B (Form 990) (2021)
Page 4
Name of organization
The Susan G Komen Breast Cancer Foundation Inc
  		Employer identification number

75-1835298
Part III
Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10) that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet$  
Use duplicate copies of Part III if additional space is needed.
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
Schedule B (Form 990) (2021)
Additional Data


Software ID: 21014044
Software Version: 2021v4.2
SCHEDULE C
(Form 990)

Department of the Treasury
Internal Revenue Service
Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527

SchCMd Bullet Complete if the organization is described below. SchCMd Bullet Attach to Form 990 or Form 990-EZ.
SchCMd BulletGo to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2021
Open to Public
Inspection
If the organization answered "Yes" on Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" on Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" on Form 990, Part IV, Line 5 (Proxy Tax) (see separate instructions) or Form 990-EZ, Part V, line 35c (Proxy Tax) (see separate instructions), then
Round Bullet Section 501(c)(4), (5), or (6) organizations: Complete Part III.
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number

75-1835298
Part I-A
Complete if the organization is exempt under section 501(c) or is a section 527 organization.

1
Provide a description of the organization’s direct and indirect political campaign activities in Part IV. See instructions for definition of “political campaign activities."

2
Political campaign activity expenditures. See instructions ....................................................................SchCMd Bullet
$  
3
Volunteer hours for political campaign activities. See instructions ..................................................................
 

Part I-B
Complete if the organization is exempt under section 501(c)(3).
1
Enter the amount of any excise tax incurred by the organization under section 4955 ................................SchCMd Bullet
$  
2
Enter the amount of any excise tax incurred by organization managers under section 4955 .......................SchCMd Bullet
$  
3
If the organization incurred a section 4955 tax, did it file Form 4720 for this year? .........................................
4a
Was a correction made? ......................................................................................................................
b
If "Yes," describe in Part IV.
Part I-C
Complete if the organization is exempt under section 501(c), except section 501(c)(3).
1
Enter the amount directly expended by the filing organization for section 527 exempt function activities ..... SchCMd Bullet
$  
2
Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ............................................................................................................................SchCMd Bullet

$  
3
Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b...........SchCMd Bullet

$  
4
Did the filing organization file Form 1120-POL for this year? ...................................................................
5
Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.
(a) Name (b) Address (c) EIN (d) Amount paid from filing organization's funds. If none, enter -0-. (e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.
1
2
3
4
5
6
For Paperwork Reduction Act Notice, see the instructions for Form 990.
Cat. No. 50084S
Schedule C (Form 990) 2021

Schedule C (Form 990) 2021
Page 2
Part II-A
Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).
A Check SchCMd Bulletexpenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet
Limits on Lobbying Expenditures
(The term "expenditures" means amounts paid or incurred.) 		(a) Filing
organization's
totals 		(b) Affiliated group totals
1a Total lobbying expenditures to influence public opinion (grass roots lobbying) ...................... 26,906 26,906
b Total lobbying expenditures to influence a legislative body (direct lobbying) ........................ 178,091 178,447
c Total lobbying expenditures (add lines 1a and 1b) ............................................................ 204,997 205,353
d Other exempt purpose expenditures ............................................................................... 88,434,283 98,589,124
e Total exempt purpose expenditures (add lines 1c and 1d) .................................................. 88,639,280 98,794,477
f Lobbying nontaxable amount. Enter the amount from the following table in both
columns.		 1,000,000 1,000,000
If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
Not over $500,00020% of the amount on line 1e.
Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
Over $17,000,000$1,000,000.
g Grassroots nontaxable amount (enter 25% of line 1f) ................................................. 250,000 250,000
h Subtract line 1g from line 1a. If zero or less, enter -0-. ................................................ 0 0
i Subtract line 1f from line 1c. If zero or less, enter -0-. ................................................ 0 0
j If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting
section 4911 tax for this year? ...................................................................................................................

4-Year Averaging Period Under Section 501(h)
(Some organizations that made a section 501(h) election do not have to complete all of the five
columns below. See the separate instructions for lines 2a through 2f.)
Lobbying Expenditures During 4-Year Averaging Period
Calendar year (or fiscal year
beginning in) 		(a) 2018 (b) 2019 (c) 2020 (d) 2021 (e) Total
2a Lobbying nontaxable amount 1,000,000 1,000,000 1,000,000 1,000,000 4,000,000
b Lobbying ceiling amount
(150% of line 2a, column(e)) 		6,000,000
c Total lobbying expenditures 279,269 343,462 172,474 204,997 1,000,202
d Grassroots nontaxable amount 250,000 250,000 250,000 250,000 1,000,000
e Grassroots ceiling amount
(150% of line 2d, column (e))		 1,500,000
f Grassroots lobbying expenditures 64,115 86,368 386,160 26,906 563,549
Schedule C (Form 990) 2021


Schedule C (Form 990) 2021
Page 3
Part II-B
Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).
For each "Yes" response on lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.
(a)
Yes|No
(b)
Amount
1
During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:
a
Volunteers? ...........................................................................................................
 
 
b
Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ........
 
 
c
Media advertisements? ...................................................................................................
 
 
 
d
Mailings to members, legislators, or the public? .............................................................................
 
 
 
e
Publications, or published or broadcast statements? ...........................................................
 
 
 
f
Grants to other organizations for lobbying purposes? ..........................................................
 
 
 
g
Direct contact with legislators, their staffs, government officials, or a legislative body? .......................
 
 
 
h
Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ..................
 
 
 
i
Other activities? ...................................................................................................................
 
 
 
j
Total. Add lines 1c through 1i ....................................................................................................
 
2a
Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....
 
 
b
If "Yes," enter the amount of any tax incurred under section 4912 ...........................................
 
c
If "Yes," enter the amount of any tax incurred by organization managers under section 4912 ...................
 
d
If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? ........................
 
 
Part III-A
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).
Yes
No
1
Were substantially all (90% or more) dues received nondeductible by members? ...............................................
1
 
 
2
Did the organization make only in-house lobbying expenditures of $2,000 or less? ............................................
2
 
 
3
Did the organization agree to carry over lobbying and political expenditures from the prior year? .................................
3
 
 
Part III-B
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."
1
Dues, assessments and similar amounts from members ......................................................................
1
 
2
Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political expenses for which the section 527(f) tax was paid).
a
Current year .............................................................................................................................
2a
 
b
Carryover from last year ............................................................................................................
2b
 
c
Total ...........................................................................................................................................
2c
 
3
Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .
3
 
4
If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ......................................................................................................................
4
 
5
Taxable amount of lobbying and political expenditures. See Instructions .........................................
5
 
Part IV
Supplemental Information
Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, lines 1 and 2 (see instructions), and Part ll-B, line 1. Also, complete this part for any additional information.
Return Reference Explanation
Schedule C, Part II-A Lobbying Expenses Public policy and advocacy initiatives have the potential to impact all people touched by breast cancer. Recognizing the importance of this work to accomplish its mission, Komen supports advocacy and lobbying efforts to achieve legislative and regulatory solutions designed to support key patient protections, expand access to high-quality care and fund critical breast health programs and cancer research.
Schedule C (Form 990) 2021


Additional Data


Software ID: 21014044
Software Version: 2021v4.2

SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet Attach to Form 990.
SchDMd Bullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2021
Open to Public Inspection
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number

75-1835298
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .........    
2 Aggregate value of contributions to (during year)    
3 Aggregate value of grants from (during year)    
4 Aggregate value at end of year ........    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised funds are the organization’s property, subject to the organization’s exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................
Part II
Conservation Easements.
Complete if the organization answered "Yes" on Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ...................... 2a  
b Total acreage restricted by conservation easements .................... 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 7/25/06, and not on a historic structure listed in the National Register ... 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............
6
Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................
9
In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under FASB ASC 958, not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under FASB ASC 958, to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:
(i)
Revenue included on Form 990, Part VIII, line 1 .........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under FASB ASC 958 relating to these items:
a
Revenue included on Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 52283D
Schedule D (Form 990) 2021

Schedule D (Form 990) 2021
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b If "Yes," explain the arrangement in Part XIII and complete the following table: Amount
c Beginning balance ............................. 1c  
d Additions during the year ............................ 1d  
e Distributions during the year .......................... 1e  
f Ending balance ................................ 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability? ...
b
If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ....
Part V
Endowment Funds.
Complete if the organization answered "Yes" on Form 990, Part IV, line 10.
(a) Current year (b) Prior year (c) Two years back (d) Three years back (e) Four years back
1a Beginning of year balance .... 1,342,173 1,337,562 1,333,603 1,362,090 1,377,855
b Contributions ... 0 0 0 0  
c Net investment earnings, gains, and losses 10,613 10,279 9,803 -4,016 10,034
d Grants or scholarships ... 0 0 0 0  
e Other expenditures for facilities
and programs ... 		5,918 5,668 5,844 24,267 25,799
f Administrative expenses .... 0 0 0 204 0
g End of year balance ...... 1,346,868 1,342,173 1,337,562 1,333,603 1,362,090
2
Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:
a
Board designated or quasi-endowment SchDMd Bullet74 %
b
Permanent endowment SchDMd Bullet24 %
c
Term endowment SchDMd Bullet2 %
The percentages on lines 2a, 2b, and 2c should equal 100%.
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) Unrelated organizations .................
3a(i)
 
No
(ii) Related organizations .................
3a(ii)
 
No
b
If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
 
4
Describe in Part XIII the intended uses of the organization's endowment funds.
Part VI
Land, Buildings, and Equipment.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.
Description of property (a) Cost or other basis
(investment) 		(b) Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .....      
b Buildings ....        
c Leasehold improvements   83,890 66,413 17,477
d Equipment ....   2,171,260 1,724,500 446,760
e Other .....   9,807,274 6,626,040 3,181,234
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..SchDMdBullet 3,645,471
Schedule D (Form 990) 2021

Schedule D (Form 990) 2021
Page 3
Part VII
Investments - Other Securities.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(1) Financial derivatives.........    
(2) Closely-held equity interests........    
(3) Other
(A) PRIVATE EQUITY FUND		 43,470,000 F
(B)
(C)
(D)
(E)
(F)
(G)
(H)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)Small Bullet 43,470,000
Part VIII
Investments - Program Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.
(a) Description of investment (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.
(a) Description (b) Book value
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........Small Bullet  
Part X
Other Liabilities.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.
1.(a) Description of liability (b) Book value
(1) Federal income taxes  
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)Small Bullet 0
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII
Schedule D (Form 990) 2021

Schedule D (Form 990) 2021
Page 4
Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total revenue, gains, and other support per audited financial statements ....... 1  
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains (losses) on investments .... 2a  
b Donated services and use of facilities ......... 2b  
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIII.) ............ 2d  
e Add lines 2a through 2d ..................... 2e  
3 Subtract line 2e from line 1.................. 3  
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a  
b Other (Describe in Part XIII.) ........... 4b  
c Add lines 4a and 4b.................... 4c  
5 Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ...... 5  
Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total expenses and losses per audited financial statements ........... 1  
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities ......... 2a  
b Prior year adjustments ............ 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIII.) ............ 2d  
e Add lines 2a through 2d.................... 2e  
3 Subtract line 2e from line 1................... 3  
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a  
b Other (Describe in Part XIII.) ............ 4b  
c Add lines 4a and 4b..................... 4c  
5 Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ...... 5  
Part XIII
Supplemental Information
Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b; Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.
Return Reference Explanation
Schedule D, Part V, Line 4 Intended uses of endowment funds KOMEN HAS THREE PERMANENT ENDOWMENTS: GOODMAN-BRINKER, FIRNBERG, AND A GENERAL ENDOWMENT. THE GOODMAN-BRINKER ENDOWMENT IS FOR BREAST CANCER RESEARCH FELLOWSHIPS, THE FIRNBERG ENDOWMENT IS FOR BREAST CANCER EDUCATIONAL PROGRAMS AND RESEARCH AWARDS, AND THE GENERAL ENDOWMENT'S EARNINGS ARE RESTRICTED FOR ORGANIZATIONAL MISSION ACTIVITIES.
Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS AT MARCH 31, 2022
Schedule D (Form 990) 2021


Additional Data


Software ID: 21014044
Software Version: 2021v4.2




SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990, Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990.Right pointing arrow large image Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2021
Open to Public Inspection
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number

75-1835298
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of its grants and
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in the region (d) Activities conducted in region (by type) (such as, fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in the region		 (f) Total expenditures
for and investments
in the region
East Asia and the Pacific 0 1 Grantmaking Patient Care 500
East Asia and the Pacific 0 2 Grantmaking Research 182,226
Europe (Including Iceland and Greenland) 0 1 Fundraising Fundraising Support 13,402
Europe (Including Iceland and Greenland) 0 4 Grantmaking Research 221,030
Europe (Including Iceland and Greenland) 0 1 Program Services Learning Mgmt System 16,189
Europe (Including Iceland and Greenland) 0 1 Program Services Legal Services 7,113
Europe (Including Iceland and Greenland) 0 1 Program Services Professional Membership 3,288
North America (Canada & Mexico only) 0 3 Grantmaking Research 149,156
North America (Canada & Mexico only) 0 1 Program Services Advocacy 47,096
North America (Canada & Mexico only) 0 1 Program Services Mission Tool Development 500,639
North America (Canada & Mexico only) 0 1 Program Services Professional Membership 2,000
North America (Canada & Mexico only) 0 1 Program Services Software Licenses 22,482
Middle East and North Africa 0 1 Grantmaking Treatment 19,998
           
           
           
           
3a Sub-total .... 0 19 1,185,119
b Total from continuation sheets to Part I ... 0 0 0
c Totals (add lines 3a and 3b) 0 19 1,185,119
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2021
Schedule F (Form 990) 2021
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of noncash
assistance 		(h) Description
of noncash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
East Asia and the Pacific Research 135,000 Electronic Fund or Wire Transfer      
East Asia and the Pacific Research 47,226 Electronic Fund or Wire Transfer      
North America (Canada & Mexico only) Research 58,749 Electronic Fund or Wire Transfer      
North America (Canada & Mexico only) Research 74,992 Electronic Fund or Wire Transfer      
North America (Canada & Mexico only) Research 15,415 Electronic Fund or Wire Transfer      
Europe (Including Iceland and Greenland) Research 51,878 Electronic Fund or Wire Transfer      
Europe (Including Iceland and Greenland) Research 74,685 Electronic Fund or Wire Transfer      
Europe (Including Iceland and Greenland) Research 89,467 Electronic Fund or Wire Transfer      
Sub-Saharan Africa Treatment 19,998 Electronic Fund or Wire Transfer      
             
             
             
             
             
             
             
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......MediumBullet
9
3 Enter total number of other organizations or entities .......................MediumBullet
0
Schedule F (Form 990) 2021
Schedule F (Form 990) 2021Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
noncash
assistance 		(g) Description
of noncash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2021
Schedule F (Form 990) 2021
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; don't file with Form 990). . . . . . . . . . . . . . . . . . . . . . . .
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; don't file with Form 990).. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule F (Form 990) 2021
Schedule F (Form 990) 2021
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information. See instructions.
ReturnReference Explanation
Schedule F, Part I, Line 2 Procedures for monitoring use of grant funds AS OUTLINED IN KOMEN'S POLICIES AND PROCEDURES FOR RESEARCH AND TRAINING GRANTS, ALL GRANTEES ARE REQUIRED TO SUBMIT SCIENTIFIC PROGRESS REPORTS AND FINANCIAL REPORTS IN THE FORMAT REQUIRED BY KOMEN AND IN ACCORDANCE WITH THE SCHEDULE SET FORTH IN THE POLICIES AND ANY CHANGE REQUESTS THEY MAY HAVE FOR THEIR PROJECTS. ALL PROGRESS REPORTS AND REQUESTS ARE REVIEWED BY QUALIFIED STAFF. SEE SCHEDULE I, PART IV AND SCHEDULE O, PART IX, LINE 1 NARRATIVE FOR ADDITIONAL DETAILS.
Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements EAST ASIA AND THE PACIFIC-Accrual,; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual,; MIDDLE EAST AND NORTH AFRICA-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual
Schedule F, Part II, Line 1 Method used to account for expenditures on org's financial statements EAST ASIA AND THE PACIFIC-Accrual,; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; SUB-SAHARAN AFRICA-Accrual
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2021
Additional Data


Software ID: 21014044
Software Version: 2021v4.2



SCHEDULE G (Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Information Regarding
Fundraising or Gaming Activities
Complete if the organization answered "Yes" on Form 990, Part IV, lines 17, 18, or 19, or if the organization entered more than $15,000 on Form 990-EZ, line 6a. right arrowAttach to Form 990 or Form 990-EZ.
right arrowGo to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2021
Open to Public Inspection
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number

75-1835298
Part I
Fundraising Activities.Complete if the organization answered "Yes" on Form 990, Part IV, line 17.
Form 990-EZ filers are not required to complete this part.
1
Indicate whether the organization raised funds through any of the following activities. Check all that apply.
a e
b f
c g
d
2a
Did the organization have a written or oral agreement with any individual (including officers, directors, trustees
or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?
b
If "Yes," list the 10 highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization.


(i) Name and address of individual
or entity (fundraiser) 		(ii) Activity (iii) Did fundraiser have custody or control of contributions? (iv) Gross receipts
from activity 		(v) Amount paid to
(or retained by)
fundraiser listed in
col. (i) 		(vi) Amount paid to
(or retained by)
organization
Yes No
 
Event 360
55 E Jackson Blvd Suite 1010
 
Chicago, IL60604 		Fundraising Consultant   No 7,185,057 576,810 6,608,247
 
Revunami Inc
228 E 85th St Suite 9C
 
New York, NY10028 		Marketing Consultant   No   20,593 -20,593
 
RKD Group LLC
3400 Waterview Parkway Suite 250
 
Richardson, TX75080 		Fundraising Consultant   No 27,711,220 578,703 27,132,517
 
Armstrong McGuire LLC
PO Box 6485
 
Raleigh, NC27628 		Fundraising Consultant   No   5,600 -5,600
             
             
             
             
             
             
Total . . . . . . . . . . . . . . . . . . . . right arrow 34,896,277 1,181,706 33,714,571
3
List all states in which the organization is registered or licensed to solicit contributions or has been notified it is exempt from registration or licensing.
CA, CO, CT, DC, FL, GA, AL, HI, ID, IL, IN, IA, KS, KY, LA, ME, AK, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, AZ, RI, SC, SD, TN, TX, UT, VT, VA, AR, WA, WV, WI, WY
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 50083H
Schedule G (Form 990) 2021
Schedule G (Form 990) 2021
Page 2
Part II
Fundraising Events. Complete if the organization answered "Yes" on Form 990, Part IV, line 18, or reported more than $15,000 of fundraising event contributions and gross income on Form 990-EZ, lines 1 and 6b. List events with gross receipts greater than $5,000.









VerticalRevenue
(a) Event #1

Race-Walk Events
(event type) 		(b) Event #2

3 Day Event
(event type) 		(c) Other events

32
(total number) 		(d) Total events
(add col. (a) through col. (c))

1
Gross receipts . . . . .
14,499,847
9,614,231
1,904,776
26,018,854

2
Less: Contributions . . . .
14,043,859
9,343,514
1,653,863
25,041,236
3 Gross income (line 1 minus
line 2) . . . . . .
455,988
270,717
250,913
977,618



VerticalDirectExpenses
4 Cash prizes . . . . . 0 0 0 0
5 Noncash prizes . . . . 304,015 10,334 31,084 345,433
6 Rent/facility costs . . . . 79,551 268,834 130,022 478,407
7 Food and beverages . . . 117,659 293,462 69,402 480,523
8 Entertainment . . . . 11,009 0 20,165 31,174
9 Other direct expenses . . . 1,431,367 1,122,211 261,842 2,815,420
10 Direct expense summary. Add lines 4 through 9 in column (d) . . . . . . . . . . right arrow 4,150,957
11 Net income summary. Subtract line 10 from line 3, column (d). . . . . . . . . . right arrow -3,173,339
Part III
Gaming. Complete if the organization answered "Yes" on Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.
VerticalRevenue
(a) Bingo (b) Pull tabs/Instant
bingo/progressive bingo 		(c) Other gaming (d) Total gaming (add col.(a) through col.(c))

1
Gross revenue . . . . .
 
 
 
 
VerticalDirectExpenses

2
Cash prizes . . . . .
 
 
 
 

3
Noncash prizes . . . .
 
 
 
 

4
Rent/facility costs . . . .
 
 
 
 

5
Other direct expenses . . .
 
 
 
 


6

Volunteer labor . . . .
%
%
%


7
Direct expense summary. Add lines 2 through 5 in column (d) . . . . . . . . . . right arrow
 

8
Net gaming income summary. Subtract line 7 from line 1, column (d). . . . . . . . . right arrow
 

9
Enter the state(s) in which the organization conducts gaming activities:
a
Is the organization licensed to conduct gaming activities in each of these states? . . . . . . . .
b
If "No," explain:
 
10a
Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? . . .
b
If "Yes," explain:
 
Schedule G (Form 990) 2021
Schedule G (Form 990) 2021
Page 3
11
Does the organization conduct gaming activities with nonmembers? . . . . . . . . . . .
12
Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity
formed to administer charitable gaming? . . . . . . . . . . . . . . . . .
13
Indicate the percentage of gaming activity conducted in:
a
The organization's facility . . . . . . . . . . . . . . . . . .
13a
%
b
An outside facility . . . . . . . . . . . . . . . . . . . .
13b
%
14
Enter the name and address of the person who prepares the organization's gaming/special events books and records:
Name right arrow
Address right arrow
15a
Does the organization have a contract with a third party from whom the organization receives gaming
revenue? . . . . . . . . . . . . . . . . . . . . . . . .
b
If "Yes," enter the amount of gaming revenue received by the organization right arrow $   and the
amount of gaming revenue retained by the third party right arrow $   .
c
If "Yes," enter name and address of the third party:
Name right arrow
Address right arrow
16
Gaming manager information:
Name right arrow
Gaming manager compensation right arrow $  
Description of services provided right arrow
 
17
Mandatory distributions:
a
Is the organization required under state law to make charitable distributions from the gaming proceeds to
retain the state gaming license? . . . . . . . . . . . . . . . . . . .
b
Enter the amount of distributions required under state law distributed to other exempt organizations or spent
in the organization's own exempt activities during the tax year right arrow$  
Part IV
Supplemental Information. Provide the explanations required by Part I, line 2b, columns (iii) and (v); and Part III, lines 9, 9b, 10b, 15b, 15c, 16, and 17b, as applicable. Also provide any additional information. See instructions.
Return Reference Explanation
Schedule G, Part II Net Income Summary Gross receipts are reduced by the amount of fundraising contributions, per IRS instructions. The contributions for fiscal year 2022 were $25,041,236
Schedule G (Form 990) 2021
Additional Data


Software ID: 21014044
Software Version: 2021v4.2

Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990.
lBullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2021
Open to Public
Inspection
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number
75-1835298
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient
that received more than $5,000. Part II can be duplicated if additional space is needed.
(a) Name and address of organization
or government		 (b) EIN (c) IRC section
(if applicable)		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
noncash assistance		 (h) Purpose of grant
or assistance
(1) Baylor College of Medicine
One Baylor Plaza BCM 206
Houston,TX77030 		74-1613878 501c(3) 175,000       Research
(2) Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston,MA02215 		04-2103881 501c(3) 149,729       Research
(3) University of OKlahoma
PO Box 36901
Oklahoma City,OK731260901 		73-1563627 501c(3) 9,539       Education
(4) Boston University
225 Bay State Rpad
Boston,MA02215 		04-2103547 501c(3) 100,000       Research
(5) Brigham and Women's Hospital
181 Longwood Ave 5th Fl
Boston,MA02115 		04-2312909 501c(3) 61,803       Research
(6) Cancer Care
275 Seventh Avenue
New York,NY10001 		13-1825919 501c(3) 29,274       Education
(7) Columbia University Med Ctr
722 West 168th St 4th Fl
New York,NY10032 		13-5598093 501c(3) 260,000       Research
(8) Dana-Farber Cancer Institute Inc
450 Brookline Ave BP 412
Boston,MA02215 		04-2263040 501c(3) 1,385,042       Research
(9) Duke University Medical Center
PO Box 602651
Charlotte,NC282602651 		56-0532129 501c(3) 140,000       Research
(10) Emory University
1599 Clifton Rd NE 4th Fl
Atlanta,GA30322 		58-0566256 501c(3) 148,222       Research
(11) Federacio De Clubes Michoacanos
1638 S Blue Island Ave
Chicago,IL60608 		41-2061019 501c(3) 29,175       Screening
(12) Fred Hutchinson Cancer Research Center
PO Box 19024
Seattle,WA98109 		56-3744111 501c(3) 225,000       Research
(13) Fulton County Health Department
700 East Oak Street
Canton,IL61520 		37-6000896 501c(3) 5,438       Screening
(14) Harvard Medical School
Holyoke Center Room 600
1350 Massachusetts Avenue
Cambridge,MA02138 		04-2103580 501c(3) 100,000       Research
(15) Indiana University (Indianapolis)
Financial Mgmt Svcs PO Box 66057
Indianapolis,IN462666057 		35-6001673 501c(3) 716,595       Research
(16) Intermountain Healthcare Foundation Inc
36 South State Street
Salt Lake City,UT84111 		94-2854057 501c(3) 9,375       Research
(17) Johns Hopkins University
1101 East 33rd Street Eastern C220
Baltimore,MD21218 		52-0595110 501c(3) 834,671       Research
(18) Lake County Health Department
3010 Grand Avenue
Waukegan,IL60085 		59-3502843 501c(3) 5,105       Screening
(19) Leland Stanford Jr University
PO Box 44253
San Francisco,CA941444253 		94-1156365 501c(3) 200,000       Research
(20) Massachusetts Institute of Technology
160 Memorial Drive
Cambridge,MA02139 		04-2103594 501c(3) 200,000       Research
(21) Mayo Clinic Jacksonville
Griffin Building Room 170
4500 San Pablo Road
Jacksonville,FL32224 		59-3337028 501c(3) 400,000       Research
(22) McDonough County Health Department
505 E Jackson Street
Macomb,IL61455 		37-6001537 501c(3) 4,419       Screening
(23) Memorial Sloan-Kettering Cancer Ctr
633 Third Avenue 28th Floor
New York,NY10017 		13-1924236 501c(3) 425,000       Research
(24) Mountain Park Health Cntr
3003 N 3rd Street Suite 1600
Phoenix,AZ85012 		86-0498020 501c(3) 16,667       Education
(25) North Carolina Central University
1801 Fayetteville Street
Durham,NC27707 		56-6000730 501c(3) 50,809       Research
(26) Northwestern University - Chicago
633 Clark Room G547
Evanston,IL60208 		36-2167817 501c(3) 224,933       Research
(27) Oregon Health & Science University
0690 SW Bancroft
Portland,OR97239 		75-2668014 501c(3) 468,663       Research
(28) Princeton University
701 Carnegie Center Suite 413
Princeton,NJ08540 		21-0634501 501c(3) 100,000       Research
(29) Providence Portland Medical Center
PO Box 13993
Portland,OR97213 		93-0386906 501c(3) 165,000       Research
(30) Roswell Park Alliance Foundation
Department of Immunology
Elm Carlton Streets
Buffalo,NY14263 		16-1391608 501c(3) 60,000       Research
(31) Rush University Medical Center
1700 W Van Buren St Suite 250
Chicago,IL60612 		36-2174823 501c(3) 200,000       Research
(32) Stanford University
PO Box 44253
San Francisco,CA941444253 		94-1156365 501c(3) 100,000       Screening
(33) Stephenson County Health Department
10 West Linden Street
Freeport,IL61032 		36-6006654 501c(3) 5,125       Research
(34) SUNY at Stony Brook
W5510 Melville Library
Stony Brook,NY11794 		14-1368361 501c(3) 110,607       Education
(35) Supporting Our Sisters International Inc
2604 Pinebrook Ave C2
Hyattsville,MD20785 		47-2511778 501c(3) 2,500       Screening
(36) Tazewell County Health Department
21306 Illinois Rt 9
Tremont,IL615689252 		37-6002170 501c(3) 27,593       Screening
(37) The Ohio State University College
700 Childrens Drive
Columbus,OH43205 		31-6025986 501c(3) 142,485       Research
(38) The University of Chicago
970 East 58th Street 3rd Fl
Chicago,IL60637 		36-2177139 501c(3) 389,674       Research
(39) The Wistar Institute
3601 Spruce Street
Philadelphia,PA191044265 		23-6434390 501c(3) 165,000       Research
(40) Tufts University
800 Washington Street
Boston,MA02111 		04-3400617 501c(3) 66,840       Research
(41) UnityPoint Health-MethodistProctor
5409 N Knoxville Ave
Peoria,IL61614 		51-0186460 501c(3) 9,928       Screening
(42) Univ of Colorado Health Sciences Cent
13001 E 17TH PLACE
Denver,CO802910238 		73-1563627 501c(3) 92,496       Research
(43) Univ of North Carolina at Chapel Hill
104 Airport Drive Suite 2200
CB 1350
Chapel Hill,NC275991350 		56-6001393 501c(3) 775,531       Research
(44) Univ of Texas MD Anderson Cancer Center
PO Box 4390
Houston,TX772104390 		74-6001118 501c(3) 495,766       Research
(45) University of Alabama at Birmingham
1530 3rd Avenue South Room 1170
Birmingham,AL352940111 		63-6005396 501c(3) 90,000       Research
(46) University of California at San Francisco
3333 California St Suite 315
San Francisco,CA94118 		94-6036493 501c(3) 100,000       Research
(47) Loyola University Chicago
820 N Michigan Ave Ste 1300
Chicago,IL60611 		36-1408475 501c(3) 165,000       Research
(48) University of Massachusetts Amherst
Goodell Bldg Room 405 Box 33210
Amherst,MA010033210 		04-3167352 501c(3) 37,109       Research
(49) University of Michigan
Alexandra Thebaud Wolverine Tower
Ann Arbor,MI481091274 		38-6006309 501c(3) 423,873       Research
(50) University of North Carolina
104 Airport Drive Suite 2200
CB 1350
Chapel Hill,NC275999525 		56-6001393 501c(3) 100,000       Research
(51) University of Notre Dame du Lac
836a Grace Hall
Notre Dame,IN465565612 		35-0868188 501c(3) 60,000       Research
(52) University of Pennsylvania
3451 Walnut Street
P-211 Franklin Bldg
Philadelphia,PA191046205 		23-1352685 501c(3) 211,881       Research
(53) University of Pittsburgh
123 University Place Suite B21
Pittsburgh,PA152132303 		25-0966691 501c(3) 120,000       Research
(54) University of Pittsburgh
3100 Cathedral Learning
Pittsburgh,PA15260 		25-0965591 501c(3) 210,000       Research
(55) University of South Carolina
1600 Hampton Street Suite 404H
Columbia,SC29208 		57-6001153 501c(3) 53,727       Research
(56) University of Utah
201 South Presidents Circle
Room 406
Salt Lake City,UT841129020 		87-6000525 501c(3) 220,000       Research
(57) University of Washington
3917 University Way NE
Seattle,WA98105 		74-1586031 501c(3) 115,000       Research
(58) UT HSC - San Antonio
7703 Floyd Curl Drive
San Antonio,TX772293900 		74-1586031 501c(3) 209,959       Research
(59) UT Southwestern Medical Center
5323 Harry Hines Blvd
Dallas,TX753909020 		74-6000203 501c(3) 579,255       Research
(60) Utah Cancer Control Program
PO Box 144620
Salt Lake City,UT841144620 		87-6000545 501c(3) 30       Education
(61) Valleywise Health Foundation
2901 E Camelback Rd Ste 202
Phoenix,AZ85016 		86-0777567 501c(3) 16,667       Education
(62) Vanderbilt University Medical Center
Dept AT 40303
Atlanta,GA311920303 		62-0476822 501c(3) 627,363       Research
(63) Virginia Commonwealth University
800 E Leigh St Suite 3100
Richmond,VA232843039 		54-6001758 501c(3) 75,000       Research
(64) VNA of Fox Valley
400 North Highland Ave
Aurora,IL60506 		36-2182095 501c(3) 19,992       Screening
(65) Wake Forest University Health Sciences
Grants Mgmt Medical Ctr Blvd
WinstonSalem,NC27157 		22-3849199 501c(3) 90,000       Research
(66) Wayne State University
5057 Woodward AVE 13th Floor
Detroit,MI48202 		36-6028429 501c(3) 18,789       Research
(67) Winnebago County Health Department
555 NCourt St PO Box 4009
Rockford,IL611100509 		36-4529968 501c(3) 6,097       Screening
(68) Yale University
2 Whitney Avenue 6th Floor
New Haven,CT06510 		03-0179440 501c(3) 135,000       Research
2
Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image
67
3
Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image
0
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2021

Schedule I (Form 990) 2021
Page 2
Part III
Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Number of
recipients		 (c) Amount of
cash grant		 (d) Amount of
noncash assistance		 (e) Method of valuation (book,
FMV, appraisal, other)		 (f) Description of noncash assistance
(1) Patient Care Assistance @ $300 4894 1,468,200 0 fmv 0
(2) Patient Care Assistance @$500 3666 1,833,000 0 fmv 0
(3) Patient Care Assistance @ $750 705 528,750 0 fmv 0
(3)
(4)
(5)
(6)
(7)
Part IV
Supplemental Information. Provide the information required in Part I, line 2; Part III, column (b); and any other additional information.
Return Reference Explanation
Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds. SUSAN G. KOMEN'S (KOMEN) POLICIES FOR MANAGING GRANTS FROM THE TIME OF PRE-AWARD THROUGH CLOSEOUT ARE DESIGNED TO MAXIMIZE FLEXIBILITY WHILE MAINTAINING A HIGH STANDARD OF ACCOUNTABILITY AND PRESERVING THE INTEGRITY OF THE REVIEW AND AWARD PROCESS. KOMEN REQUIRES ALL GRANTEES TO SIGN A GRANT AGREEMENT SETTING FORTH THE TERMS OF THE GRANT, INCLUDING: PURPOSE, AMOUNT, BUDGETARY RESTRICTIONS, DURATION, PAYMENT SCHEDULE, REPORTING REQUIREMENTS, AUDIT, AND EARLY TERMINATION RIGHTS. FOR RESEARCH GRANTS, SCIENTIFIC PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED THROUGHOUT THE GRANT TERM BY A PH.D. OR MASTERS-LEVEL RESEARCH GRANT MANAGER. FOR COMMUNITY HEALTH AND EDUCATION GRANTS, PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED OR SUPERVISED THROUGHOUT THE GRANT TERM BY QUALIFIED PROFESSIONALS SERVING AS GRANTS MANAGERS. AS OUTLINED IN KOMEN'S POLICIES AND PROCEDURES FOR RESEARCH AND TRAINING GRANTS, GRANTEES ARE REQUIRED TO SUBMIT PROGRESS AND FINANCIAL REPORTS DETAILING PROGRESS TOWARD AIMS AND OBJECTIVES, MAJOR ACCOMPLISHMENTS, KEY DELIVERABLES AND CHALLENGES ENCOUNTERED, WITH A FULL ACCOUNTING OF GRANT FUNDS EXPENDED (ACTUAL VERSUS BUDGETED EXPENSES) AND WRITTEN JUSTIFICATION OF EXPENSES. AS APPROPRIATE, THE GRANTS MANAGER MAY CONDUCT SITE VISITS WITH GRANTEES TO GAIN A BETTER UNDERSTANDING OF THEIR WORK AND ADDRESS ANY CHALLENGES IMPACTING THE FUNDED PROGRAM. ALL GRANT FUNDS MUST BE EXPENDED IN ACCORDANCE WITH THE PROJECT'S APPROVED BUDGET AND ARE DISBURSED IN ACCORDANCE WITH THE SCHEDULE DOCUMENTED WITHIN THE GRANT AGREEMENT. REQUESTS FOR CHANGES TO THE DESIGN OF THE FUNDED PROJECT OR BUDGET ARE SUBJECT TO PRIOR APPROVAL BY KOMEN IN ACCORDANCE WITH THE TERMS OF THE GRANT AGREEMENT. AS PART OF ITS OVERSIGHT PRACTICES, THE TERMS OF THE GRANT AGREEMENT MAY PROVIDE KOMEN WITH, AMONG OTHER THINGS, THE RIGHT TO REQUEST WITH REASONABLE PRIOR NOTICE TO THE GRANTEE: (1) ADDITIONAL PROGRESS AND/OR FINANCIAL REPORTING FROM THE GRANTEE, (2) GRANTEE PARTICIPATION IN SITE VISITS, TELEPHONE CONFERENCES, PRESENTATIONS, OR OTHER SPEAKING ENGAGEMENTS, AND (3) WITH PRIOR WRITTEN NOTICE, ADJUSTMENT TO THE PROJECT REPORTING PERIOD AND ASSOCIATED DISBURSEMENT OF GRANT FUNDS AT ANY TIME DURING THE GRANT TERM. SEE SCHEDULE O, PART IX, LINE 1 NARRATIVE FOR ADDITIONAL DETAILS.
Schedule I (Form 990) 2021



Additional Data


Software ID: 21014044
Software Version: 2021v4.2


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
SchJMediumBullet Attach to Form 990.
SchJMediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2021
Open to Public Inspection
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number

75-1835298
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .....
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a? ....
2
 
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? .............
4a
 
No
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
 
No
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ....................
5a
 
No
b
Any related organization? .......................
5b
 
No
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ..................
6a
 
No
b
Any related organization? ......................
6b
 
No
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
 
No
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................
8
 
No
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2021

Schedule J (Form 990) 2021
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2, 1099-MISC compensation, and/or 1099-NEC (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation in column (B) reported as deferred on prior Form 990
(i) Base
compensation 		(ii) Bonus & incentive
compensation 		(iii) Other reportable compensation
1Dana Brown
 
Chief Operating Officer 		(i)

(ii)		 415,375
-------------
0 		46,800
-------------
0 		3,362
-------------
0 		13,948
-------------
0 		1,689
-------------
0 		481,174
-------------
0 		0
-------------
0
2Eunice Nakamura
 
General Counsel & Corporate Secretary 		(i)

(ii)		 241,539
-------------
0 		26,400
-------------
0 		1,534
-------------
0 		8,188
-------------
0 		6,148
-------------
0 		283,809
-------------
0 		0
-------------
0
3Paula Schneider
 
President and CEO 		(i)

(ii)		 609,111
-------------
0 		68,805
-------------
0 		4,604
-------------
0 		15,875
-------------
0 		15,537
-------------
0 		713,932
-------------
0 		0
-------------
0
4Ria Williams
 
Chief Financial Officer 		(i)

(ii)		 259,268
-------------
0 		29,046
-------------
0 		1,869
-------------
0 		7,341
-------------
0 		14,441
-------------
0 		311,965
-------------
0 		0
-------------
0
5Lori Maris
 
SVP, Ops Services & Support 		(i)

(ii)		 217,465
-------------
0 		24,102
-------------
0 		1,710
-------------
0 		4,012
-------------
0 		8,584
-------------
0 		255,873
-------------
0 		0
-------------
0
6Catherine Olivieri
 
SVP, Human Resources 		(i)

(ii)		 256,095
-------------
0 		30,000
-------------
0 		3,362
-------------
0 		8,941
-------------
0 		13,639
-------------
0 		312,037
-------------
0 		0
-------------
0
7Victoria Wolodzko
 
SVP, Mission 		(i)

(ii)		 302,964
-------------
0 		34,800
-------------
0 		2,503
-------------
0 		6,710
-------------
0 		3,019
-------------
0 		349,996
-------------
0 		0
-------------
0
8Kimberly Johnson
 
Former Sr. Director AAHEI 		(i)

(ii)		 170,979
-------------
0 		10,000
-------------
0 		1,445
-------------
0 		0
-------------
0 		1,769
-------------
0 		184,193
-------------
0 		0
-------------
0
9Srinivasu Avadhanula
 
VP, BI Platfm & Eng 		(i)

(ii)		 216,663
-------------
0 		23,643
-------------
0 		1,414
-------------
0 		5,964
-------------
0 		1,946
-------------
0 		249,630
-------------
0 		0
-------------
0
10Kari Bodell
 
VP, Dev Progs Strat 		(i)

(ii)		 203,596
-------------
0 		24,600
-------------
0 		1,409
-------------
0 		5,942
-------------
0 		2,013
-------------
0 		237,560
-------------
0 		0
-------------
0
11Sarah Rosales
 
VP, Corp Partnerships 		(i)

(ii)		 213,743
-------------
0 		18,450
-------------
0 		1,285
-------------
0 		3,525
-------------
0 		13,273
-------------
0 		250,276
-------------
0 		0
-------------
0
12Kimberly Sabelko
 
VP, Sci Strat & Programs 		(i)

(ii)		 185,656
-------------
0 		15,000
-------------
0 		1,556
-------------
0 		5,008
-------------
0 		10,715
-------------
0 		217,935
-------------
0 		0
-------------
0
13Michelle Strong
 
VP, Marketing Strat 		(i)

(ii)		 204,015
-------------
0 		20,000
-------------
0 		1,592
-------------
0 		6,888
-------------
0 		6,207
-------------
0 		238,702
-------------
0 		0
-------------
0
Schedule J (Form 990) 2021

Schedule J (Form 990) 2021
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference Explanation
Schedule J (Form 990) 2021

Additional Data


Software ID: 21014044
Software Version: 2021v4.2
SCHEDULE M
(Form 990)

Department of the Treasury
Internal Revenue Service
Noncash Contributions
Right pointing arrow large imageComplete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image Attach to Form 990.
Right pointing arrow large imageGo to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2021
Open to Public Inspection
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number

75-1835298
Part I
Types of Property
(a)
Check if applicable 		(b)
Number of contributions or items contributed 		(c)
Noncash contribution amounts reported on
Form 990, Part VIII, line 1g 		(d)
Method of determining
noncash contribution amounts
1 Art—Works of art ....        
2 Art—Historical treasures .        
3 Art—Fractional interests ..        
4 Books and publications ..      
5 Clothing and household
goods ....... 		X 30,975 Cost
6 Cars and other vehicles ..        
7 Boats and planes ....        
8 Intellectual property ...        
9 Securities—Publicly traded .        
10 Securities—Closely held stock .        
11 Securities—Partnership, LLC,
or trust interests .... 		       
12 Securities—Miscellaneous ..        
13 Qualified conservation
contribution—Historic
structures ..... 		       
14 Qualified conservation
contribution—Other ... 		       
15 Real estate—Residential .        
16 Real estate—Commercial ..        
17 Real estate—Other ...        
18 Collectibles .....        
19 Food inventory ...        
20 Drugs and medical supplies .        
21 Taxidermy ......        
22 Historical artifacts ....        
23 Scientific specimens ..        
24 Archeological artifacts ...        
25 Other Right pointing arrow large image ( Gift bags/Gift Cards ) X 30 41,795 Cost
26 Other Right pointing arrow large image ( Goods Inventory ) X 34 96,622 Cost
27 Other Right pointing arrow large image ( Photography ) X 1 35 Cost
28 Other Right pointing arrow large image ( Supplies ) X 4 8,900 Cost
Other Right pointing arrow large image ( Tickets ) X 3 400 Cost
Other Right pointing arrow large image ( Travel ) X 2 3,600 Cost
29
Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement
29
 
Yes
No
30a
During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that it must hold for at least three years from the date of the initial contribution, and which isn't required to be used for exempt purposes for the entire holding period? ...................
30a
 
No
b
If "Yes," describe the arrangement in Part II.
31
Does the organization have a gift acceptance policy that requires the review of any nonstandard contributions?
31
 
No
32a
Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash
contributions? ..........................
32a
 
No
b
If "Yes," describe in Part II.
33
If the organization didn't report an amount in column (c) for a type of property for which column (a) is checked,
describe in Part II.
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 51227J
Schedule M (Form 990) (2021)
Schedule M (Form 990) (2021)
Page 2
Part IISupplemental Information. Provide the information required by Part I, lines 30b, 32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.
Return Reference Explanation
Schedule M (Form 990) (2021)

Additional Data


Software ID: 21014044
Software Version: 2021v4.2
SCHEDULE O
(Form 990)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
MediumBullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2021
Open to Public
Inspection
Name of the organization
The Susan G Komen Breast Cancer Foundation Inc
 
Employer identification number

75-1835298
Return Reference Explanation
Form 990, Part I, Line 6 VOLUNTEERS VOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE MORE THAN PINK WALKS, RACE FOR THE CURE RUNS, AND THE SUSAN G. KOMEN 3 DAY SERIES.
Form 990, Part III, Line 4 Program service accomplishments SUSAN G. KOMEN'S MISSION IS TO SAVE LIVES FROM BREAST CANCER, BY FINDING BREAKTHROUGHS TO PREVENT, DETECT, TREAT, AND CURE BREAST CANCER, AND BY MEETING MOST CRITICAL NEEDS IN COMMUNITIES TO ENSURE EVERYONE GETS THE BREAST CANCER CARE THEY NEED WHEN THEY NEED IT. KOMEN TAKES A 360 DEGREE APPROACH TO FIGHT BREAST CANCER THROUGH . RESEARCH, TO DRIVE BREAKTHROUGHS THAT WILL BRING US NEW KNOWLEDGE AND ADVANCES IN CARE FOR ALL, . COMMUNITY HEALTH, TO EMPOWER PEOPLE WITH TRUSTWORTHY INFORMATION AND SUPPORT PEOPLE IN THEIR BREAST HEALTH JOURNEY THROUGH DIRECT SERVICES, COMMUNITY PROGRAMS AND HEALTH SYSTEMS CHANGE. . AND PUBLIC POLICY, WHERE WE ADVOCATE FOR POLICIES TO CREATE SYSTEMIC AND LASTING CHANGES THAT WILL FUND AND FACILITATE RESEARCH AND ALLEVIATE THE BURDEN ON PATIENTS AND PROTECT ACCESS TO AFFORDABLE, HIGH-QUALITY HEALTH CARE FOR ALL. KOMEN IS A LEADING GLOBAL BREAST CANCER ORGANIZATION, HAVING FUNDED MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT OUTSIDE OF THE U.S. GOVERNMENT WHILE PROVIDING REAL TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED nearly $1.1 BILLION IN BREAST CANCER RESEARCH IN MORE THAN 2700 GRANTS AND more than 500 CLINICAL TRIALS CONDUCTED BY THOUSANDS OF THE WORLD'S BEST AND BRIGHTEST RESEARCHERS ACROSS THE US AND AROUND THE WORLD. KOMEN HAS ALSO PROVIDED OVER $2.3 BILLION IN FUNDING FOR PATIENT NAVIGATION, SCREENING, DIAGNOSIS, TREATMENT, EDUCATION , ADVOCACY, AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 60 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. WITH THIS INVESTMENT, KOMEN IS SUPPORTING LABORATORY RESEARCH, TRANSLATIONAL STUDIES, AND CLINICAL TRIALS THAT ARE PAVING THE ROAD WITH SCIENTIFIC DISCOVERIES THAT ARE: - UNRAVELLING THE BIOLOGY OF BREAST CANCER, - LEADING TO THE DEVELOPMENT OF NEW BREAST CANCER DRUGS, - DEVELOPMENT OF NEW TECHNOLOGIES AND TESTS, AND - NEW INTERVENTIONS THAT ARE CHANGING THE STANDARD OF BREAST CANCER CARE AND IMPROVING THE DELIVERY OF THAT CARE. OUR GOAL IS TO ADVANCE PERSONALIZED MEDICINE AND IMPROVE HEALTH OUTCOMES FOR EVERYONE. KOMEN HAS HAD MORE THAN 680 RESEARCH DISCOVERIES SINCE WE STARTED TRACKING THEM IN 2016 THAT ARE MOVING US CLOSER TO THAT GOAL. NEARLY TWO-THIRDS OF THESE DISCOVERIES FOCUS ON OUR RESEARCH PRIORITIES OF CONQUERING METASTATIC AND AGGRESSIVE BREAST CANCERS AND ELIMINATING BREAST CANCER DISPARITIES. THEY INCLUDE SUCH THINGS AS NEW BIOMARKERS, NEW DRUG TARGETS, NEW TREATMENTS, AND NEW HEALTHCARE DELIVERY TOOLS IN PAVING THIS ROAD WITH SCIENTIFIC DISCOVERIES, WE'RE ALSO PAVING IT WITH HOPE. THE HOPE THAT NEW WAYS TO DETECT, DIAGNOSE, TREAT, PREVENT AND, ULTIMATELY, CURE BREAST CANCER ARE AROUND THE CORNER. THERE WHEN PEOPLE WITH BREAST CANCER NEED THEM TO ALLOW THEM TO LIVE LONGER, WITH IMPROVED QUALITY OF LIFE. RESEARCH SINCE ITS FOUNDING IN 1982, KOMEN'S RESEARCH INVESTMENTS HAVE CONTRIBUTED TO MANY MAJOR ADVANCES IN BREAST CANCER SCIENCE. THE PROGRESS HAS BEEN SIGNIFICANT - TODAY, WE KNOW THAT BREAST CANCER IS MORE THAN A SINGLE DISEASE. WE HAVE A BETTER UNDERSTANDING OF THE GENETICS OF BREAST CANCER AND THE CRITICAL NEED TO TAILOR SCREENING, DIAGNOSIS, TREATMENT, AND PREVENTION STRATEGIES TO INDIVIDUALS THROUGH ADVANCES IN PRECISION MEDICINE. KOMEN'S RESEARCH PROGRAMS ARE FOCUSED ON BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER THROUGH BETTER APPROACHES FOR EARLY DETECTION AND DIAGNOSIS, UNDERSTANDING METASTASIS AND RECURRENCE, DEVELOPING NOVEL THERAPIES FOR ALL STAGES OF BREAST CANCER, AND DEVELOPING NEW APPROACHES TO ADDRESS DISPARITIES IN BREAST CANCER OUTCOMES, WITH THE GOAL OF SUPPORTING WORK THAT HAS SIGNIFICANT POTENTIAL TO LEAD TO NEW TREATMENTS, TECHNOLOGIES AND INTERVENTIONS. KOMEN'S RESEARCH PROGRAMS ARE GUIDED BY 46 OF THE WORLD'S LEADERS IN BREAST CANCER RESEARCH, ONCOLOGY AND ADVOCACY. THE SCIENTIFIC ADVISORY BOARD ASSISTS KOMEN IN SETTING ITS RESEARCH STRATEGY AND PRIORITIZING ITS RESEARCH INVESTMENT. THE KOMEN SCHOLARS LEAD AND PARTICIPATE IN KOMEN'S WORLD-CLASS SCIENTIFIC PEER REVIEW PROCESS. OUR ADVOCATES IN SCIENCE BRING THE COLLECTIVE PATIENT VOICE TO KOMEN'S RESEARCH PROGRAMS AND SCIENTIFIC ACTIVITIES, EMPHASIZING URGENCY AND PATIENT IMPACT. THIS YEAR WE ANNOUNCED THE NEW CLASS OF SIX ESTEEMED BREAST CANCER RESEARCHERS AND TWO NEW PATIENT ADVOCATES TO THE KOMEN SCHOLARS. THESE WOMEN AND MEN JOIN AN EXCLUSIVE GROUP OF BREAST CANCER RESEARCHERS, CLINICIANS AND ADVOCATES WHO HELP GUIDE THE ORGANIZATION'S WORK TO SAVE LIVES AND END BREAST CANCER. KOMEN AWARDS GRANTS TO INDIVIDUAL SCIENTISTS, RESEARCH TEAMS, AND ORGANIZATIONS AROUND THE WORLD THROUGH A FAIR, TRANSPARENT, RIGOROUS, AND COMPETITIVE REVIEW PROCESS THAT ENSURES MAXIMUM IMPACT FOR OUR RESEARCH INVESTMENT. IN FY22, KOMEN AWARDED 48 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, IN THE UNITED STATES, AND CANADA. CAREER CATALYST RESEARCH GRANTS SUPPORT EARLY CAREER INVESTIGATORS CONDUCTING OUTSTANDING RESEARCH THAT WILL USE LIQUID BIOPSY TECHNOLOGY TO IMPROVE THE TREATMENT AND EARLY DETECTION OF METASTATIC BREAST CANCER. LEADERSHIP GRANTS SUPPORT KOMEN SCHOLARS PURSUING INNOVATIVE RESEARCH PROJECTS WHICH WILL IMPROVE THE UNDERSTANDING, DETECTION, TREATMENT OR PREVENTION OF BREAST CANCER, WITH A FOCUS ON CONQUERING METASTATIC BREAST CANCER AND ELIMINATING BREAST CANCER DISPARITIES. THE 48 RESEARCH GRANTS AWARDED IN FY22 ARE: CAREER CATALYST RESEARCH GRANTS: DANIEL HOLLERN, PH.D., OF SALK INSTITUTE FOR BIOLOGICAL STUDIES WILL IDENTIFY WAYS THAT METASTATIC TUMOR CELLS AVOID OR SUPPRESS THE IMMUNE SYSTEM'S B CELLS IN TRIPLE NEGATIVE BREAST CANCER (TNBC) PATIENTS, SPECIFICALLY PATIENTS THAT ALSO HAVE LIVER TUMORS. THE GOAL IS TO IMPROVE AN EXISTING TREATMENT CALLED ANTI-PDL1 THERAPY TO HELP BOOST B CELL ACTIVITY AND REDUCE MORTALITY IN TNBC PATIENTS WITH LIVER TUMORS. HARUKA ITAKURA, M.D., PH.D., OF STANFORD UNIVERSITY SCHOOL OF MEDICINE WILL CONDUCT A STUDY THAT WILL TAKE EXISTING MRI AND CT IMAGES COLLECTED FROM HER2+ BREAST CANCER PATIENTS AND USE ADVANCED DATA SCIENCE/AI TO IDENTIFY KEY FACTORS FOR PREDICTING FUTURE BRAIN METASTASIS. THE GOAL OF THIS STUDY IS TO USE NON-INVASIVE TECHNIQUES TO IDENTIFY PATIENTS WITH HER2+ BREAST CANCER WHO ARE ALSO AT RISK FOR DEVELOPING METASTATIC BRAIN TUMORS. MARIYA ROZENBLIT, M.D., OF YALE CANCER CENTER WILL CONDUCT A CLINICAL TRIAL TO EVALUATE VARIOUS THERAPIES OFFERED TO PATIENTS WITH STAGE 4 OLIGOMETASTATIC BREAST CANCER (OMBC) AND TO CREATE AN ONLINE PLATFORM THAT REGISTERS STAGE 4 OMBC PATIENTS, STANDARDIZES THE TREATMENT APPROACH AND ENABLES FOLLOW-UP DATA COLLECTION. DR. ROZENBLIT HOPES THIS COLLECTED DATA WILL DEMONSTRATE HOW THESE TREATMENT OPTIONS MAY PROMOTE LONG-TERM SURVIVAL AND FUTURE PREVENTION OF METASTATIC BREAST CANCER FOR THESE PATIENTS. TARAH BALLINGER, M.D., OF INDIANA UNIVERSITY WILL PILOT A 16-WEEK EXERCISE INTERVENTION FOR METASTATIC BREAST CANCER (MBC) PATIENTS TO DETERMINE WHETHER THE ADDITION OF EXERCISE TO THEIR COMPREHENSIVE CARE PLAN COULD IMPROVE LONG-TERM TREATMENT OUTCOMES. MARIA SOSA, PH.D., OF ICHAN SCHOOL OF MEDICINE WILL STUDY THE EFFECTIVENESS OF A NEW PROPOSED DRUG THERAPY THAT WILL BLOCK THE ACTIVITY OF ZFP296, A PROTEIN THAT IS BELIEVED TO PROMOTE TUMOR CELL GROWTH AND METASTASIS. PEDRAM RAZAVI, M.D., PH.D., OF MEMORIAL SLOAN KETTERING CANCER CENTER WILL ANALYZE CIRCULATING TUMOR CELL DNA (CTDNA) FROM EARLY-STAGE, HIGH RISK PATIENTS TO DETECT EARLY BREAST CANCER METASTASES OR ANY REMAINING BREAST CANCER CELLS AFTER TREATMENT (MINIMAL RESIDUAL DISEASE, OR MRD). DR. RAZAVI WILL USE THIS CTDNA TO IDENTIFY PERSONALIZED TREATMENTS FOR PATIENTS AT RISK FOR DEVELOPING MRD OR TREATMENT RESISTANCE, WITH THE ULTIMATE GOAL OF DECREASING THE RISK OF METASTATIC RECURRENCE AND MORTALITY. HAI WANG, PH.D., OF ROSWELL PARK CANCER INSTITUTE WILL STUDY BREAST CANCER CELL METASTASIS TO THE BONE AND THE METABOLIC CHANGES THESE METASTATIC CELLS GO THROUGH TO GROW IN THE BONE VERSUS THE PRIMARY TUMOR LOCATION IN THE BREAST. DR. WANG WILL INVESTIGATE HOW BREAST CANCER TUMOR CELLS THAT METASTASIZE TO THE BONE SWITCH THEIR SOURCE OF METABOLIC ENERGY PRODUCTION AND AIMS TO USE THESE FINDINGS TO EXPLORE NEW TREATMENT STRATEGIES THAT COULD IMPROVE SURVIVAL RATES FOR METASTATIC BREAST CANCER PATIENTS.
Form 990, Part III, Line 4 Program service accomplishments continued SONYA REID, M.D., M.P.H., OF VANDERBILT UNIVERSITY WILL CONDUCT A CLINICAL TRIAL FOR PATIENTS WITH HORMONE RECEPTOR-POSITIVE (HR+, HER2-) METASTATIC BREAST CANCER (MBC) TO DETERMINE WHETHER A GENE PANEL TEST FOR GENETIC VARIATIONS IN HR+, HER2- MBC COULD INFORM MORE EFFECTIVE TREATMENT STRATEGIES, ESPECIALLY FOR BREAST CANCER TYPES THAT ARE MORE PREVALENT IN RACIAL/ETHNIC MINORITIES. THE GOAL OF THIS PROJECT IS TO CHARACTERIZE THE IMPACT OF GENETIC VARIATION ON MBC SURVIVAL AND DISPARATE OUTCOMES, AND TO DEVELOP MORE PERSONALIZED TREATMENTS THAT COULD IMPACT CLINICAL OUTCOMES AMONG A RACIALLY DIVERSE PATIENT POPULATION. SRINIVAS MALLADI, PH.D., OF THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER WILL STUDY AND TARGET DORMANT BREAST CANCER CELLS TO PREVENT THEM FROM RECURRING AND METASTASIZING TO THE BRAIN AND INTERACTING WITH BRAIN CELLS CALLED ASTROCYTES. BY ANALYZING HOW ASTROCYTES NOURISH NEIGHBORING BREAST CANCER CELLS IN THE BRAIN WITH FATTY ACIDS, THE GOAL IS TO EVALUATE THE IMPACT OF TARGETING THE CREATION OF THESE FATTY ACIDS TO PREVENT METASTATIC RECURRENCE. LEADERSHIP GRANTS: MELINDA TELLI, M.D., OF STANFORD UNIVERSITY WILL CONDUCT TWO CLINICAL TRIALS USING LIQUID BIOPSY TO TEST FOR CIRCULATING TUMOR DNA, AN INDICATOR OF RISK FOR RELAPSE IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER (TNBC). THE HOPE IS THAT THIS LIQUID BIOPSY TECHNIQUE CAN BE USED TO MONITOR PATIENTS WHO ARE AT HIGHER RISK FOR A TNBC RELAPSE AND ALLOW FOR BETTER, MORE PERSONALIZED TREATMENTS. LAJOS PUSZTAI, M.D., OF YALE CANCER CENTER WILL TEST AN INNOVATIVE NEW TOOL FOR MEASURING TUMOR GROWTH, A NEW BIOMARKER FOR TRIPLE NEGATIVE BREAST CANCER (TNBC) TREATMENT GUIDANCE AND A NEW ANTI-CANCER THERAPY TARGETING CANCER METABOLISM. DR. PUSZTAI HOPES TO IMPROVE TNBC OUTCOMES AND PREVENT RECURRENCE OF METASTATIC TUMORS THROUGH THIS WORK. JULIE PALMER, SC.D., M.P.H., OF BOSTON UNIVERSITY WILL CONDUCT A STUDY THAT WILL USE TUMOR SAMPLES AND PSYCHOSOCIAL STRESS DATA FROM WOMEN ENROLLED IN THE BLACK WOMEN'S HEALTH STUDY TO DEMONSTRATE HOW PSYCHOSOCIAL STRESS IMPACTS BREAST CANCER BIOLOGY AND OUTCOMES. THE GOAL OF THIS PROJECT IS TO UNDERSTAND HOW PSYCHOSOCIAL STRESS INFLUENCES BREAST CANCER AND TO IDENTIFY POTENTIAL INTERVENTIONS TO REDUCE PSYCHOSOCIAL STRESS, AND TO REDUCE DISPARITIES IN BREAST CANCER MORTALITY FOR BLACK WOMEN. KOMEN SCIENTIFIC ADVISORY BOARD MEMBER KORNELIA POLYAK, M.D., PH.D., OF DANA FARBER CANCER INSTITUTE WILL DETERMINE HOW THE SIGNALING OF THE PROTEIN TRANSFORMING GROWTH FACTOR BETA (TGF) MAY CONTRIBUTE TO EARLY BREAST CANCER DEVELOPMENT, INCLUDING A SMALL MUTATION THAT IS MORE PREVALENT IN AFRICAN AMERICAN WOMEN. THIS RESEARCH WILL HELP TO IDENTIFY AT-RISK POPULATIONS AND POTENTIAL THERAPEUTIC TARGETS, WITH THE GOAL OF BETTER UNDERSTANDING AND ENDING BREAST CANCER HEALTH DISPARITIES AMONG AFRICAN AMERICAN WOMEN. YIBIN KANG, PH.D., OF PRINCETON UNIVERSITY WILL INVESTIGATE WHETHER THE ENZYME ALDH1A2 COULD BE A THERAPEUTIC TARGET FOR PREVENTING BREAST CANCER PROGRESSION. THE GOAL OF THIS RESEARCH IS TO BETTER UNDERSTAND THE IMMUNE SYSTEM'S IMPACT ON BREAST CANCER DEVELOPMENT AND TREATMENT WHILE ALSO EXPLORING THE THERAPEUTIC POTENTIAL OF ALDH1A2 AS A NEW TARGET TO ELIMINATE BREAST TUMORS AND METASTASIS. SOHRAB SHAH, PH.D., OF MEMORIAL SLOAN-KETTERING CANCER CENTER WILL PERFORM A STUDY USING TRIPLE-NEGATIVE BREAST CANCER (TNBC) TUMOR DNA AND LIQUID BIOPSY SAMPLES TO OBSERVE HOW IMMUNE CELLS AND TUMOR DNA MUTATIONS CAN EVOLVE OVER TIME WITH TREATMENT OR DISEASE PROGRESSION. THE GOAL OF THIS PROJECT IS TO DEVELOP A PREDICTIVE MODEL THAT CAN IDENTIFY THE OPTIMAL TIMEFRAME FOR INTERVENTION AFTER NEOADJUVANT CHEMOTHERAPY FOR TNBC PATIENTS THAT ARE AT THE HIGHEST RISK OF RELAPSE. STEFFI OESTERREICH, PH.D., OF UNIVERSITY OF PITTSBURGH WILL UNCOVER THE EVOLUTION OF ESTROGEN RECEPTOR POSITIVE (ER+) PRIMARY CANCER TO METASTATIC RECURRENCE USING TISSUE SAMPLES AND LIQUID BIOPSY, AND TO CREATE GUIDELINES FOR A RAPID AUTOPSY PROGRAM TO BETTER UNDERSTAND METASTATIC DISEASE. THIS WORK WILL CREATE RICH DATASETS FOR OTHER RESEARCHERS AND UNCOVER BETTER TREATMENT OPTIONS FOR PREVENTING THE RECURRENCE OF METASTATIC TUMORS. AMELIE RAMIREZ, DR.P.H., M.P.H., OF THE UNIVERSITY OF TEXAS HEALTH SCIENCES CENTER AT SAN ANTONIO WILL STUDY THE IMPACT OF A CULTURALLY ADAPTED, HOLISTIC BREAST CANCER SURVIVORSHIP PROGRAM ON LATINA BREAST CANCER SURVIVORS THAT INCLUDES YOGA, MEDITATION AND DIETARY GUIDANCE. THE GOAL OF THIS PROJECT IS TO IDENTIFY WHETHER A HOLISTIC SURVIVORSHIP PROGRAM CAN IMPROVE THE QUALITY OF LIFE AND HEALTH OUTCOMES FOR LATINA BREAST CANCER SURVIVORS. ALANA WELM, PH.D., OF THE UNIVERSITY OF UTAH WILL RESEARCH A MOLECULE CALLED SHORT FORM OF RON (SFRON) THAT IS CURRENTLY BEING STUDIED IN CLINICAL TRIALS AS A THERAPEUTIC TARGET TO BLOCK BREAST CANCER TUMOR AND METASTASIS GROWTH. DR. WELM WILL STUDY SFRON TO DETERMINE HOW IT FUNCTIONS IN METASTASIS, AND THE ANTI-TUMOR IMMUNE RESPONSE OF THE BODY. THE GOAL OF THIS PROJECT IS TO IDENTIFY HOW SFRON AND THE IMMUNE SYSTEM MAY BE HARNESSED TO DEVELOP MORE EFFECTIVE TREATMENTS FOR PATIENTS WITH METASTATIC BREAST CANCER. LEADERSHIP GRANTS - NEW KOMEN SCHOLARS: ALLISON KURIAN, M.D., OF STANFORD UNIVERSITY WILL TEST AN ETHNICALLY DIVERSE STUDY GROUP OF PATIENTS USING A NEW LIQUID BIOPSY TECHNIQUE THAT CAN DETECT PRIMARY AND RECURRENT BREAST CANCER AT AN EARLIER STAGE USING LESS GENETIC MATERIAL. THE GOAL OF THIS PROJECT IS TO IDENTIFY WHICH PATIENT POPULATIONS COULD BENEFIT FROM EARLIER BREAST CANCER DETECTION USING THIS NEW STRATEGY. SUNIL BADVE, M.D., FRCPATH, OF EMORY UNIVERSITY WILL STUDY THE STRUCTURAL DIVERSITY OF BREAST CANCER PATIENT TUMOR CELLS AND THEIR RESISTANCE TO TREATMENTS THAT USE CDK 4/6 INHIBITORS, AND TO USE THIS DATA TO DEVELOP NEW THERAPEUTIC STRATEGIES TO PREVENT RESISTANCE AND RECURRENCE NANCY LIN, M.D., OF DANA FARBER CANCER INSTITUTE WILL EXPLORE WAYS TO IMPROVE THE EFFECTIVENESS OF ANTIBODY-DRUG CONJUGATES FOR PATIENTS WITH METASTATIC BREAST CANCER (MBC). BY USING TISSUE AND PLASMA SAMPLES FROM PATIENTS TREATED WITH THESE DRUGS, DR. LIN AIMS TO UNCOVER HOW TO PREVENT RESISTANCE TO THESE THERAPIES OVER TIME AND IMPROVE LONG-TERM TREATMENT OUTCOMES FOR MBC PATIENTS. SARA M. TOLANEY, M.D., M.P.H., OF DANA FARBER CANCER INSTITUTE WILL TEST THE ABILITY OF AN ANTIBODY-DRUG CONJUGATE DRUG CALLED SACITUZUMAB GOVITECAN (SG) TO INCREASE RESPONSIVENESS TO PEMBROLIZUMAB TREATMENT IN METASTATIC TRIPLE NEGATIVE BREAST CANCER AND HR+/HER2- METASTATIC BREAST CANCER PATIENTS. THIS RESEARCH WILL HELP DETERMINE WHETHER COMBINATION THERAPY USING BOTH SG AND PEMBROLIZUMAB COULD IMPROVE LONG-TERM SURVIVAL OUTCOMES FOR MBC PATIENTS. CYNTHIA MA, M.D., PH.D., OF WASHINGTON UNIVERSITY WILL PERFORM A STUDY USING PATIENT TUMOR SAMPLES COLLECTED POST-SURGERY AND FOLLOWING ENDOCRINE THERAPY TO IDENTIFY GENETIC CHANGES AND MECHANISMS OF ENDOCRINE RESISTANCE. DR. MA HOPES THAT THIS DATA WILL HELP TO IDENTIFY WHICH PATIENTS MAY DEVELOP RESISTANCE TO ENDOCRINE THERAPY AND GUIDE THE DEVELOPMENT OF MORE PERSONALIZED TREATMENTS THAT WILL SAVE LIVES. JORGE REIS-FILHO, M.D., PH.D., FRCPATH, OF MEMORIAL SLOAN-KETTERING CANCER CENTER WILL INVESTIGATE HOW DEFECTS TO DNA REPAIR PROCESSES CAUSE INCREASED INSTABILITY AND RESISTANCE TO ANTI-ESTROGEN THERAPY IN ESTROGEN RECEPTOR POSITIVE (ER+) BREAST CANCER CELLS. THIS RESEARCH WILL PROVIDE VALUABLE INSIGHT INTO THE EVOLUTION OF THERAPEUTIC RESISTANCE OF ER+ BREAST CANCER CELLS THAT CAN BE USED FOR FUTURE DEVELOPMENT OF MORE EFFECTIVE TREATMENTS. SCIENTIFIC ADVISORY BOARD MEMBER ADRIAN LEE, PH.D., OF THE UNIVERSITY OF PITTSBURGH WILL DEVELOP AND CHARACTERIZE A LIVING BIOBANK FROM VARIOUS NORMAL AND BREAST CANCER SPECIMENS DERIVED FROM PATIENT SAMPLES. THIS BIOBANK WILL SERVE AS A PUBLIC RESOURCE FOR RESEARCHERS WITH A FOCUS ON DIVERSITY IN RACE (ANCESTRY) AND BREAST CANCER SUBTYPES AND WILL ACCELERATE RESEARCH LEADING TO NEW INSIGHTS IN DRUG RESISTANCE AND PROGRESSION, NEW THERAPEUTIC TARGETS, AND IMPROVED CLINICAL OUTCOMES. ANGELA DEMICHELE, M.D., M.S.C.E., OF THE UNIVERSITY OF PENNSYLVANIA WILL INVESTIGATE MINIMAL RESIDUAL DISEASE AND DORMANT TUMOR CELLS BY USING NEW ASSAYS TO DETECT DISSEMINATED TUMOR CELLS AND CTDNA IN PATIENT TUMOR AND BLOOD SAMPLES. SHE WILL IDENTIFY AT-RISK PATIENTS, DIFFERENTIATE BETWEEN DORMANT AND REACTIVATED BREAST CANCER CELLS, AND MORE ACCURATELY EVALUATE THE IMPACT OF TREATMENTS ON DORMANT CELLS, WITH THE GOAL OF PREVENTING METASTATIC BREAST CANCER RECURRENCE AND DEATH AND IMPROVING THE QUALITY OF LIFE FOR SURVIVORS.
Form 990, Part III, Line 4 Program service accomplishments continued MARIANA CHAVEZ MACGREGOR, M.D., M.SC., FASCO, OF THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER WILL STUDY THE SOCIAL AND POLICY-LEVEL FACTORS THAT AFFECT BREAST CANCER PATIENTS FROM UNDERSERVED POPULATIONS WHO FREQUENTLY ENCOUNTER MORE BARRIERS TO SUCCESSFUL TREATMENT THAN OTHER PATIENTS. THE GOAL IS TO IDENTIFY WHAT FACTORS CREATE THESE DISPARITIES AND DEVELOP STRATEGIES THAT WILL STRENGTHEN THE QUALITY OF CARE AND IMPROVE TREATMENT OUTCOMES FOR UNDERSERVED PATIENTS. MBC COLLABORATIVE RESEARCH INITIATIVE MELISSA TROESTER M.D., PH.D. AND TERRY HYSLOP PH.D. ARE COLLABORATING ON A PROPOSAL TO LEVERAGE HIGH QUALITY, INDIVIDUAL-LEVEL TUMOR BIOLOGY AND SOCIAL DETERMINANTS OF HEALTH DATA IN THE CAROLINA BREAST CANCER STUDY (CBCS) DATA TOGETHER WITH COMMUNITY-LEVEL VARIABLES TO EVALUATE HOW STRESS CONTRIBUTES TO HIGHER METASTASIS AND WORSE BREAST CANCER OUTCOMES IN BLACK WOMEN WHEN COMPARED TO WHITE WOMEN. ZACH HARTMAN PH.D. AND BENJAMIN VINCENT M.D. WILL WORK TOGETHER ON A PROPOSAL TO DETERMINE HOW TO MAKE METASTATIC TRIPLE-NEGATIVE BREAST CANCERS MORE SENSITIVE TO IMMUNOTHERAPIES. THE COLLABORATORS PROPOSE A METHOD OF STIMULATING THE ANTI-TUMOR RESPONSE WITH VACCINE TECHNOLOGIES TO INDUCE A SUSTAINABLE, ROBUST, AND BROAD STIMULUS TO THE INNATE IMMUNE SYSTEM THAT WILL BE TESTED FOR THE ABILITY TO ELIMINATE DISTANT METASTASIS. JENIFER FREEDMAN PH.D., STEVEN PATIERNO PH.D., AND KATIE HOADLEY, PH.D. ARE COLLABORATING TO INVESTIGATE DIFFERENCES IN BREAST CANCER OUTCOME BY RACE AS BLACK WOMEN SUFFER DISPROPORTIONATELY AND WITH OFTEN A WORSE PROGNOSIS. THE STUDY LEADERS IDENTIFIED BIOLOGICAL DIFFERENCES IN CANCER BETWEEN AFRICAN AND EUROPEAN ANCESTRY THAT RESULTED FROM A PROCESS CALLED SPLICING. THE RESEARCHERS IN THIS PROPOSAL SEEK TO DETERMINE IF THESE DIFFERENCES CAUSE BREAST CANCER CELLS TO GROW AND SPREAD MORE QUICKLY. OPPORTUNITY GRANTS: MONICA M. BERTAGNOLLI, M.D., OF THE ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY WILL RECEIVE $249,429 TO PERFORM A GENOMIC ANALYSIS OF PAIRED GERMLINE AND PRE-TREATMENT TUMOR SAMPLES FROM POSTMENOPAUSAL WOMEN WITH STAGE 2 AND 3 ER+/HER2-NEGATIVE (HER2-) BREAST CANCER COLLECTED THROUGH THE ALTERNATE TRIAL. THE GOAL IS TO ESTIMATE THE EFFECT OF GENE MUTATIONS ON ENDOCRINE THERAPY RESISTANCE, DEVELOP BIOMARKER TESTS TO DETECT RESIDUAL DISEASE AND ADVANCE PRECISION MEDICINE CAPABILITIES IN THE FIELD OF ER+ BREAST CANCER. ETTA D. PISANO, M.D., OF THE ECOG-ACRIN CANCER RESEARCH GROUP WILL BE AWARDED $247,248 TO IMPLEMENT WAYS TO IMPROVE AFRICAN-AMERICAN PARTICIPATION IN THE TOMOSYNTHESIS MAMMOGRAPHIC IMAGING SCREENING TRIAL (TMIST) BIOSPECIMEN SUB-STUDY THROUGH THE DEVELOPMENT AND DISSEMINATION OF EDUCATIONAL MATERIALS HIGHLIGHTING THE IMPORTANCE OF PARTICIPATION IN BIOSPECIMEN RESEARCH. THIS PROJECT WILL INCREASE THE DIVERSITY OF PATIENT SAMPLES IN THE EXISTING BIOBANK THAT WILL BE USED TO SUPPORT FUTURE STUDIES FOCUSED ON BREAST CANCER SCREENING, DIAGNOSIS, AND TREATMENT INTERVENTIONS. NADINE M. TUNG, M.D., OF THE ECOG-ACRIN CANCER RESEARCH GROUP WILL BE AWARDED $249,256 TO EXPAND RESEARCH QUESTIONS IN THE COMPASSHER2 PCR TRIAL TO DETERMINE WHETHER UNIQUE BIOMARKERS IDENTIFIED IN STAGE 2 OR 3 HER2-POSITIVE (HER2+) BREAST CANCER PATIENT TUMOR SAMPLES CAN BE USED TO PREDICT OUTCOMES OF PRE-SURGERY THERAPY. THE GOAL OF THIS PROJECT IS TO PROVIDE DATA THAT CAN BE USED TO PERSONALIZE TREATMENT DECISIONS, IMPROVE QUALITY OF LIFE, AND OPTIMIZE TREATMENTS FOR PATIENTS DIAGNOSED WITH HER2+ BREAST CANCER. ANNA MARIA V. STORNIOLO, M.D., OF INDIANA UNIVERSITY (IU) WILL RECEIVE TWO OPPORTUNITY GRANTS TOTALING $1,803,000 TO SUPPORT THE SUSAN G. KOMEN TISSUE BANK (KTB) AT THE IU SIMON CANCER CENTER, THE WORLD'S ONLY BIOREPOSITORY OF NORMAL BREAST TISSUE. THESE GRANTS SUPPORT THE COLLECTION AND STORAGE OF BIOSAMPLES, INCLUDING WHOLE BLOOD, DNA, SERUM, PLASMA, AND HEALTHY BREAST TISSUE FROM WOMEN NOT KNOWN TO HAVE BREAST CANCER, AS WELL AS THE DISTRIBUTION OF THE SAMPLES TO RESEARCHERS WORLDWIDE. ACCESS TO THESE NORMAL TISSUE SAMPLES PROVIDE RESEARCHERS THE OPPORTUNITY TO UNDERSTAND THE CHANGES THAT HAPPEN IN A NORMAL BREAST AND HOW THESE MOLECULAR MECHANISMS ARE ALTERED IN THE MALIGNANT PROCESS. EDUCATION KOMEN IS A TRUSTED SOURCE OF BREAST CANCER INFORMATION FOR PEOPLE ALL OVER THE WORLD AND IS INSTRUMENTAL IN CONNECTING PEOPLE WITH THE RESOURCES THEY NEED IN THEIR FIGHT AGAINST BREAST CANCER. OUR WEBSITE, KOMEN.ORG, PROVIDES CURRENT, SAFE, ACCURATE, COMPREHENSIVE, AND UNBIASED INFORMATION ABOUT BREAST CANCER, BASED ON SCIENTIFIC EVIDENCE. CONTENT IS OFFERED IN A VARIETY OF FORMATS INCLUDING INTERACTIVE VIDEO USING ANIMATION AND VOICEOVER IN ENGLISH AND SPANISH, ILLUSTRATIONS, CHARTS, GRAPHS, AND SHORT VIDEOS TO MEET THE LEARNING PREFERENCES AND NEEDS OF OUR WEB VISITORS. THE ABOUT BREAST CANCER AND PORTIONS OF THE PATIENT & CAREGIVER SECTIONS OF KOMEN'S WEBSITE, CO-DEVELOPED WITH HARVARD MEDICAL SCHOOL FACULTY AND DANA-FARBER CANCER INSTITUTE STAFF, RECEIVED NEARLY 3 MILLION PAGE VIEWS DURING FY22. KOMEN LAUNCHED THE CLINICAL TRIALS INITIATIVE ON KOMEN.ORG WITH THE GOAL OF EDUCATING PEOPLE ABOUT THE ROLE CLINICAL TRIALS, INCLUDING THOSE FROM UNDER- REPRESENTED POPULATIONS, AND EMPOWERING PEOPLE WITH INFORMATION ON TRIALS AND RESOURCES, INCLUDING OUR CLINIAL TRIALS HELPLINE. THE RESOURCES HELP TO ENSURE PATIENTS ARE EQUIPPED TO MAKE INFORMED DECISIONS REGARDING TRIAL PARTICIPATION IN PARTNERSHIP WITH THEIR HEALTH CARE PROVIDERS. THE INITIATIVE ALSO RAISES AWARENESS OF THE DIFFERENT TYPES OF TRIALS, INCLUDING TRIALS SUPPORTED BY KOMEN, FOCUSED ON RISK, SCREENING AND EARLY DETECTION, TREATMENT, FAMILY SUPPORT, QUALITY OF LIFE AND SURVIVORSHIP. KOMEN ALSO PROVIDES EVIDENCE-BASED, EASY-TO-READ EDUCATIONAL MATERIALS IN DOWNLOADABLE FORMATS ON KOMEN.ORG. EXAMPLES OF KOMEN EDUCATIONAL MATERIALS INCLUDE: A) BREAST SELF-AWARENESS MESSAGE CARDS IN MORE THAN 40 LANGUAGES, B) BREAST CANCER SPECIFIC BROCHURES AND FACTSHEETS, C) BOOKLETS WITH SUPPORT INFORMATION FOR SURVIVORS AND CO-SURVIVORS, AND D) TOOLKITS FOR BREAST CANCER OUTREACH AND EDUCATION FOR HISPANIC/LATINO IN ENGLISH AND SPANISH, FOR BLACK AND AFRICAN AMERICAN COMMUNITIES AND FOR LESBIANS, BISEXUAL WOMEN AND TRANSGENDER AND QUESTIONING/QUEER PEOPLE. IN ADDITION, IN FY22 KOMEN CONTINUED TO SUPPORT THE METASTATIC BREAST CANCER (MBC) COMMUNITY BY HOSTING 25 VIRTUAL EVENTS THROUGH THE MBC IMPACT SERIES. THESE EVENTS PROVIDED PEOPLE LIVING WITH METASTATIC BREAST CANCER AND THEIR LOVED ONES A SAFE, COLLABORATIVE SPACE TO GATHER INFORMATION AND DISCOVER PRACTICAL RESOURCES TO HELP MAKE DECISIONS FOR IMPROVED PHYSICAL AND EMOTIONAL HEALTH. PATIENT SUPPORT AT KOMEN, WE ARE FOCUSED ON SAVING LIVES BY REMOVING BARRIERS AND ENSURING ALL PEOPLE RECEIVE THE CARE THEY NEED THROUGH KOMEN'S PATIENT CARE CENTER. OFFICIALLY LAUNCHED IN FY22, THE KOMEN PATIENT CARE CENTER IS A SUITE OF INTEGRATED DIRECT PATIENT PROGRAMS THAT ENSURE NO ONE FACES BREAST CANCER ALONE. THE PATIENT CARE CENTER PROGRAMS AND SERVICES INCLUDE THE BREAST CARE HELPLINE, SCREENING & DIAGNOSTICS PROGRAM, FINANCIAL ASSISTANCE PROGRAM, AND PATIENT NAVIGATION, ALL OF WHICH PROVIDE SUPPORT AND RESOURCES FOR PEOPLE IN LOCAL COMMUNITIES ACROSS THE COUNTRY. KOMEN'S PROGRAMS AND SERVICES REMOVE BARRIERS TO CARE AND WORK SEAMLESSLY TOGETHER SO A PERSON CAN ACCESS ALL THE PROGRAMS THROUGH ONE CENTRAL SOURCE. THE OVERARCHING GOAL OF OUR PATIENT CARE CENTER IS TO SAVE LIVES BY ENSURING PATIENTS STAY IN THE BREAST CANCER CONTINUUM OF CARE, OVERCOME BARRIERS AND CHALLENGES TO HIGH-QUALITY BREAST CARE SERVICES, COMPLETE TREATMENT, AND HAVE A HIGH QUALITY OF LIFE AND IMPROVED LONG-TERM OUTCOMES. THE PATIENT CARE CENTER SERVED ALMOST 27,000 PEOPLE IN FY22. METASTATIC BREAST CANCER COLLABORATIVE RESEARCH INITIATIVE KOMEN LAUNCHED THE METASTATIC BREAST CANCER COLLABORATIVE RESEARCH INITIATIVE (MBCCRI) WITH A PILOT PROGRAM AT DUKE UNIVERSITY AND THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL. THE GOAL IS TO CATALYZE AND SUPPORT MULTI-INSTITUTIONAL RESEARCH COLLABORATIONS AND BRING TOGETHER THE BEST AND BRIGHTEST RESEARCHERS AT SELECT INSTITUTIONS TO SHARE IDEAS, EXPERTISE AND RESOURCES. KOMEN WILL SUPPORT RESEARCH GRANT TO FIND BREAKTHROUGH DISCOVERIES TO END METASTATIC BREAST CANCER.
Form 990, Part III, Line 4 Program service accomplishments continued INFLAMMATORY BREAST CANCER COLLABORATIVE FOR THE FIRST TIME, KOMEN IS LEADING TO DRIVE A NEW DIAGNOSTIC DEFINITION OF BREAST CANCER, SPECIFICALLY INFLAMMATORY BREAST CANCER, A DEADLY AND AGGRESSIVE FORM OF CANCER. KOMEN HAS PARTNERED WITH THE INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION AND THE MILBURN FOUNDATION TO CONVENE PATIENT ADVOCATES, BREAST CANCER RESEARCHERS AND CLINICIANS TO REVIEW THE STATE OF IBC CARE AND RESEARCH GLOBALLY AND PROPOSE SPECIFIC INITIATIVES TO MOVE THE FIELD FORWARD. THE OUTCOME OF THE DISCUSSIONS WAS ABUNDANTLY CLEAR: THE FIELD NEEDS A FORMAL DEFINITION OF IBC. WITHOUT A CLEAR DEFINITION, BOTH PATIENT CARE AND RESEARCH SUFFER. DIAGNOSIS REMAINS SUBJECTIVE AND TREATMENT VARIABLE. THE GOAL IS TO MOVE BEYOND THE SUBJECTIVE 'CLINICAL DIAGNOSIS' TO A SET OF SPECIFIC DIAGNOSTIC CRITERIA AND SCORING SYSTEM THAT WILL ADVANCE IBC RESEARCH AND FACILITATE THE DISCOVERIES THAT WILL IMPROVE CARE OF IBC PATIENTS. A PROPOSED DEFINITION OF IBC, BASED ON A REVIEW OF CLINICAL, AND PATHOLOGIC FEATURES WAS SUBMITTED FOR PUBLICATION. BIG DATA FOR BREAST CANCER KOMEN CONTINUES WORK ON THE BIG DATA FOR BREAST CANCER INITIATIVE, WHICH IS AIMED AT USING BIG DATA TO FUEL SCIENTIFIC DISCOVERIES AND ACCELERATE THE DELIVERY OF EQUITABLE, PATIENT-FOCUSED CARE. KOMEN EMPOWERS BREAST CANCER PATIENTS, ADVOCATES AND THE PUBLIC WITH INFORMATION AND TOOLS TO MAKE DATA SHARING UNDERSTANDABLE THROUGH THE BIG DATA FOR BREAST CANCER PATIENTS EDUCATIONAL PROGRAMS. WE ALSO ADDRESS THE CHALLENGES OF INCORPORATING BIG DATA APPLICATIONS INTO BREAST CANCER RESEARCH AND CLINICAL CARE THROUGH WORKING WITH PARTNERS REPRESENTING A VARIETY OF STAKEHOLDERS IN BREAST CANCER RESEARCH. ADDITIONALLY, KOMEN SUPPORTS DATA SCIENCE PROJECTS TO IMPROVE BREAST CANCER OUTCOMES AND SAVE LIVES. PUBLIC POLICY AND ADVOCACY SUSAN G. KOMEN IS THE NONPARTISAN VOICE OF MORE THAN 3.8 MILLION BREAST CANCER SURVIVORS, THOSE LIVING WITH THE DISEASE AND THE PEOPLE WHO LOVE THEM. KOMEN WORKS TO EDUCATE PEOPLE ABOUT PUBLIC POLICY ISSUES, SO THEY ARE EMPOWERED TO BECOME FORCEFUL ADVOCATES FOR THEMSELVES AND THEIR NEIGHBORS, AND THEN UNITES THEIR COLLECTIVE VOICES FOR MAXIMUM IMPACT. THROUGH OUR CENTER FOR PUBLIC POLICY, KOMEN ENSURES THAT OUR POLICYMAKERS ARE EDUCATED ABOUT THE NEEDS OF BREAST CANCER PATIENTS AND PRIORITIZE THE ISSUES IMPACTING THEM. ONLY THROUGH INFORMED GOVERNMENT ACTION CAN WE MAKE THE BROAD, SYSTEMIC AND LASTING CHANGE REQUIRED. KOMEN'S 2021-2022 PUBLIC POLICY AND ADVOCACY PRIORITIES INCLUDED: EXPANDING ACCESS TO AFFORDABLE, HIGH-QUALITY HEALTH CARE FOR ALL PATIENT POPULATIONS; SUPPORTING INCREASED STATE AND FEDERAL FUNDING FOR BREAST CANCER RESEARCH AND INCREASED EDUCATION, UTLIZATION OF AND ACCESS TO CLINICAL TRIALS; SUPPORTING STATE AND FEDERAL FUNDING FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S (CDC) NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM (NBCCEDP); ADVOCATING FOR STATE AND FEDERAL POLICIES TO IMPROVE INSURANCE COVERAGE OF BREAST CANCER TREATMENTS, INCLUDING THOSE THAT WOULD REQUIRE ORAL PARITY, PRECLUDE SPECIALTY TIERS AND PREVENT STEP THERAPY PROTOCOLS; AND ADVOCATING FOR STATE AND FEDERAL POLICIES TO REDUCE OR ELIMINATE OUT-OF-POCKET COSTS FOR MEDICALLY NECESSARY DIAGNOSTIC IMAGING. IN ADDITION TO THE STATE AND FEDERAL WORK ON OUR PUBLIC POLICY AND ADVOCACY PRIORITIES, KOMEN ALSO ENGAGED ON ISSUES RELATED TO CUSTOM BREAST PROTHESES, GENETIC AND GENOMIC TESTING, LYMPHEDEMA, MEDICARE WAITING PERIODS, PALLIATIVE CARE, SURPRISE MEDICAL BILLING AND SURVIVORSHIP. KOMEN DEVELOPED AND IMPLEMENTED ADVOCACY CAMPAIGNS TO ENCOURAGE LAWMAKERS AND AGENCY OFFICIALS TO SUPPORT AND IMPLEMENT PROGRAMS THAT WOULD ADVANCE OUR PRIORITY ISSUES. KOMEN CONTINUED TO RECRUIT AND ENGAGE ADVOCATES TO FURTHER STRENGTHEN ITS GRASSROOTS ADVOCACY NETWORK.
Form 990, Part VI, Line 1a Executive Committee THE ORGANIZATION'S BYLAWS PROVIDE FOR AN EXECUTIVE COMMITTEE COMPRISED OF A MINIMUM OF FIVE MEMBERS INCLUDING THE BOARD CHAIR, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, AND ADDITIONAL BOARD MEMBERS, AS RECOMMENDED BY THE GOVERNANCE COMMITTEE AND APPOINTED BY THE BOARD OF DIRECTORS. MEMBERS OF THE EXECUTIVE COMMITTEE MUST EITHER BE DIRECTORS OF THE ORGANIZATION OR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE BYLAWS PROVIDE THE EXECUTIVE COMMITTEE WITH THE AUTHORITY TO: (A) APPOINT MEMBERS TO NON-STANDING COMMITTEES OF THE ORGANIZATION, AND NAME CHAIRS OF SUCH COMMITTEES; (B) AUTHORIZE UNBUDGETED DISBURSEMENTS BY THE ORGANIZATION IN ACCORDANCE WITH THE SPECIFIC EXPENDITURE AUTHORITY PRESCRIBED BY THE BOARD OF DIRECTORS; (C) EMPLOY AGENTS; AND (D) CARRY INTO EXECUTION SUCH OTHER MEASURES AS IT DETERMINES WILL PROMOTE THE PURPOSE OF THE ORGANIZATION. THE COMMITTEE ALSO MAY EXERCISE, WHEN THE BOARD IS NOT IN SESSION, ALL OF THE AUTHORITY OF THE BOARD IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF THE ORGANIZATION WITH CERTAIN EXCEPTIONS SUCH AS REPEALING ANY BOARD RESOLUTIONS, AMENDING THE ORGANIZATION'S ARTICLES OR BYLAWS, OR MERGING OR DISSOLVING THE ORGANIZATION. THIS DELEGATION DOES NOT RELIEVE THE BOARD OF ANY OF ITS RESPONSIBILITIES IMPOSED BY LAW, AND THE COMMITTEE ENDEAVORS TO LIMIT ITS EXERCISE OF AUTHORITY TO TIME SENSITIVE ISSUES.
Form 990, Part VI, Line 11b Review of form 990 by governing body MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVEL MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR SUBSEQUENT PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWS, MAKES RECOMMENDATIONS, AND APPROVES THE FORM 990 FOR PRESENTATION TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE FORM 990 PRIOR TO FILING.
Form 990, Part VI, Line 12c Conflict of interest policy KOMEN'S CONFLICT OF INTEREST POLICY REQUIRES EVERY BOARD MEMBER, OFFICER, COMMITTEE MEMBER, ADVISORY BOARD MEMBER, AND EMPLOYEE TO AVOID CONFLICTS OF INTEREST. IT ALSO REQUIRES THESE PERSONS TO REPORT ANY ACTUAL AND/OR POTENTIAL CONFLICTS OF INTEREST AS SOON AS POSSIBLE. REPORTS ARE REVIEWED BY THE GENERAL COUNSEL'S OFFICE AND/OR AUDIT COMMITTEE, AND APPROPRIATE ACTION IS TAKEN PURSUANT TO THE CONFLICT OF INTEREST POLICY. FURTHER, KOMEN PRODUCES AN ANNUAL SURVEY REQUIRING ALL BOARD MEMBERS, OFFICERS, COMMITTEE MEMBERS, ADVISORY BOARD MEMBERS, AND EMPLOYEES TO REVIEW THE CONFLICT OF INTEREST POLICY AND DISCLOSE ANY ADDITIONAL ACTUAL/POTENTIAL CONFLICTS OF INTEREST. THESE ANNUAL DISCLOSURES ARE REVIEWED IN THE SAME MANNER. THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS RECEIVES, AND REVIEWS ALL REPORTED ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AND THE RELATED ACTION TO ADDRESS THEM.
Form 990, Part VI, Line 15a Process to establish compensation of top management official THE HUMAN CAPITAL MANAGEMENT COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND BEST PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE CHIEF EXECUTIVE OFFICER; THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER KEY EMPLOYEES; GRANTING THE CHIEF EXECUTIVE OFFICER WITH THE AUTHORITY TO DETERMINE COMPENSATION LEVELS WITHIN AN APPROVED RANGE; AND ANY INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010 AND IS REVIEWED ANNUALLY. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. BENCHMARKING WAS CONDUCTED FOR THE CHIEF EXECUTIVE OFFICER AND ALL EXECUTIVE TEAM MEMBERS' COMPENSATION TO EXTERNAL MARKET DATA IN 2022, TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION.
Form 990, Part VI, Line 15b Process to establish compensation of other employees THE HUMAN CAPITAL MANAGEMENT COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND BEST PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE CHIEF EXECUTIVE OFFICER; THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER KEY EMPLOYEES; GRANTING THE CHIEF EXECUTIVE OFFICER WITH THE AUTHORITY TO DETERMINE COMPENSATION LEVELS WITHIN AN APPROVED RANGE; AND ANY INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010 AND IS REVIEWED ANNUALLY. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. BENCHMARKING WAS CONDUCTED FOR THE CHIEF EXECUTIVE OFFICER AND ALL EXECUTIVE TEAM MEMBERS' COMPENSATION TO EXTERNAL MARKET DATA IN 2022, TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION.
Form 990, Part VI, Line 19 Required documents available to the public KOMEN'S FINANCIAL STATEMENTS AND THE FORM 990 ARE PUBLICLY AVAILABLE ON OUR WEBSITE. THE CERTIFICATE OF FORMATION IS AVAILABLE FROM THE TEXAS SECRETARY OF STATE AND OTHER GOVERNING DOCUMENTS ARE MADE AVAILABLE AS REQUIRED BY STATE LAW. FORM 1023 AND THE CONFLICT OF INTEREST POLICY ARE NOT PUBLISHED ONLINE BUT ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
Form 990, Part IX, Line 1 FOR NEARLY 40 YEARS, SUSAN G. KOMEN HAS WORKED TO FULFILL ITS VISION OF CREATING A WORLD WITHOUT BREAST CANCER THROUGH ITS MISSION OF SAVING LIVES BY MEETING THE MOST CRITICAL NEEDS IN OUR COMMUNITIES AND INVESTING IN BREAKTHROUGH RESEARCH TO BETTER DETECT, PREVENT, TREAT BREAST CANCERS. OVER THE LAST TWO YEARS, KOMEN CONTINUED TO IMPLEMENT A SERIES OF CHANGES BEGUN IN 2020 TO STRENGTHEN ITS FINANCIAL AND OPERATIONAL POSITION IN RESPONSE TO THE CHANGING NEEDS OF THE BREAST CANCER COMMUNITY AND ECONOMIC CONDITIONS RESULTING FROM THE COVID-19 PANDEMIC. KOMEN HAS NEARLY COMPLETED THE CONSOLIDATION OF ALL OPERATIONS OF ITS INDEPENDENT AFFILIATES INTO ITS HEADQUARTERS ORGANIZATION, RESULTING IN A SINGLE ORGANIZATION. THIS CONSOLIDATION IS ENABLING KOMEN TO LEVERAGE THE COMBINED EXPERTISE OF ITS MISSION LEADERS TO DELIVER A UNITED MISSION PROGRAM, UTILIZING TECHNOLOGY AS A KEY DRIVER TO CONNECT TO PEOPLE WHO NEED TO ACCESS CARE WHERE THEY ARE AND TO HELP IMPROVE THE PATIENT EXPERIENCE, AS WELL AS RESULTED IN ADMINISTRATIVE AND OPERATIONAL EFFICIENCIES. CENTRAL TO KOMEN'S VISION IS A STEADFAST COMMITMENT TO INVESTING IN BREAKTHROUGH RESEARCH. KOMEN REMAINED COMMITTED TO INVESTING IN RESEARCH FOCUSED ON ITS PRIMARY FOCUS ON METASTATIC BREAST CANCER AND UNDERSTANDING AND ELIMINATING DISPARITIES IN BREAST CANCER OUTCOMES BETWEEN BLACK AND WHITE PATIENTS. DESPITE THE ECONOMIC UNCERTAINTY AND CHALLENGING FUNDRAISING ENVIRONMENT, KOMEN AWARDED $21 MILLION IN NEW RESEARCH AWARDS. WHILE WE CONTINUE TO INVEST IN RESEARCH INTO NEW TREATMENTS, KOMEN SUPPORTS PEOPLE WHO ARE FACING BREAST CANCER TODAY THROUGH A GROWING SUITE OF PATIENT CARE SERVICES, INCLUDING DIRECT FINANCIAL ASSISTANCE THROUGH ITS TREATMENT ASSISTANCE PROGRAM, ELIGIBLE TO HELP PAY FOR EXPENSES THAT MAY SERVE AS A BARRIER TO ATTAINING THE CARE NEEDED TO SURVIVE, SUCH AS CO-PAYS, TRANSPORTATION, CHILDCARE OR RENT.
Form 990, Part XI, Line 9 Other changes in net assets or fund balances RESCINDED GRANTS - 589946; Event Cost Reclass - 27703;
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990) 2021


Additional Data


Software ID: 21014044
Software Version: 2021v4.2